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PREFACE
The Occupational Safety and Health Act of 1970 emphasizes the need 
for standards to protect the health and safety of workers exposed to an 
ever-increasing number of potential hazards at their workplace. The 
National Institute for Occupational Safety and Health has projected a 
formal system of research, with priorities determined on the basis of 
specified indices, to provide relevant data from which valid criteria for 
effective standards can be derived. Recommended standards for occupational 
exposure, which are the result of this work, are based on the health 
effects of exposure. The Secretary of Labor will weigh these recommen­
dations along with other considerations such as feasibility and means of 
implementation in developing regulatory standards.
It is intended to present successive reports as research and epide­
miologic studies are completed and as sampling and analytical methods are 
developed. Criteria and standards will be reviewed periodically to ensure 
continuing protection of the worker.
I am pleased to acknowledge the contributions to this report on 
xylene by members of my staff, the valuable and constructive comments 
presented by the Review Consultants on Xylene, by the ad hoc committees of 
the American Industrial Hygiene Association and the American Medical 
Association, by Robert B. O'Connor, M.D. , NIOSH consultant in occupational 
medicine, and by William A. Burgess on respiratory protection. The
NIOSH recommendations for standards are not necessarily a consensus of all 
the consultants and professional societies that reviewed this criteria 
document on xylene. Lists of the NIOSH Review Committee members and of the 
Review Consultants appear on the following pages.
I'N i\ " r\
John F. Finklea, M.D.
Director, National Institute for 
Occupational Safety and Health
The Office of Research and Standards Development,
National Institute for Occupational Safety and 
Health, had primary responsibility for development 
of the criteria and recommended standard for xylene. 
Tabershaw-Cooper Associates developed the basic information 
for consideration by NIOSH staff and consultants under 
contract No HSM-99-73-39. Bryan D. Hardin had NIOSH 
program responsibility and served as criteria manager.
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I. RECOMMENDATIONS FOR A XYLENE STANDARD
The National Institute for Occupational Safety and Health (NIOSH) 
recommends that employee exposure to xylene in the workplace be controlled 
by adherence to the following sections. The standard is designed to pro­
tect the health and safety of workers over a working lifetime; compliance 
with all sections of the standard should therefore prevent adverse effects
of xylene on the health and safety of workers. The standard is measurable
by techniques that are valid, reproducible, and available to industry and 
government agencies. Sufficient technology exists to permit compliance 
with the recommended standard. The criteria and standard will be subject
to review and revision as necessary.
Regardless of the source of raw materials from which produced, 
"xylene" (also known as "xylol" or "dimethylbenzene") refers to any one of 
or combination of the isomers of xylene: ortho-, meta-, or para-dimethyl- 
benzene. The term "xylene" will be used throughout this document. 
"Exposure to xylene" is defined as exposure above half the recommended 
time-weighted average environmental limit. If "exposure" to other 
chemicals also occurs, for example from contamination of xylene with 
benzene, provisions of any applicable standard for the other chemicals 
shall also be followed.
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(a) Concentration
Occupational exposure to xylene shall be controlled so that workers 
are not exposed to xylene at a concentration greater than 100 parts per 
million parts of air by volume (approximately 434 milligrams per cubic 
meter of air) determined as a time-weighted average (TWA) exposure for up 
to a 10-hour workday, 40-hour workweek, with a ceiling concentration of 200 
parts per million parts of air by volume (approximately 868 milligrams per 
cubic meter of air) as determined by a sampling period of 10 minutes.
(b) Sampling, Collection, and Analysis
Procedures for collection and analysis of environmental samples shall 
be as provided in Appendices I and II or by any method shown to be 
equivalent in accuracy, precision, and sensitivity to the method specified.
Section 2 - Medical
Comprehensive preplacement and biennial (every 2 years) medical 
examinations should be provided for all workers subject to "exposure to 
xylene." The history and examination should be directed toward, but not 
limited to, the incidence of headaches, nausea or other gastrointestinal 
disturbance, dizziness, and of alcohol consumption. Particular attention 
should be focused on complaints and evidence of eye, mucous membrane, or 
skin irritation. Laboratory tests recommended at the time of the biennial 
examination include a complete blood count, a routine urinalysis, and 
appropriate liver function tests.
Section 1 - Environmental (Workplace Air)
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Section 3 - Labeling (Posting)
(a) Labeling
Containers of xylene shall carry a label stating:
XYLENE 
(XYLOL, DIMETHYLBENZENE)
WARNING! FLAMMABLE 
HARMFUL IF INHALED OR SWALLOWED 
IRRITATING TO SKIN OR EYES
Keep away from heat, sparks, and open flame.
In case of fire, use foam, dry chemical, or C02.
Avoid breathing vapor.
Avoid contact with eyes, skin, and clothing.
Keep container closed.
Use with adequate ventilation.
Do not use for washing hands, floors, or equipment.
First Aid: In case of eye or skin contact with liquid xylene, wash with
plenty of water. If eye contact, call a physician. If swallowed, call 
a physician. Do not attempt to induce vomiting.
(b) Posting
Areas where there is occupational exposure to xylene shall be posted 
with a sign reading:
XYLENE
WARNING! FLAMMABLE 
HARMFUL IF INHALED OR SWALLOWED 
IRRITATING TO SKIN OR EYES
Keep out heat, sparks, or open flames.
No smoking permitted.
In case of fire, use fire extinguishers. (Give location) 
Avoid breathing vapor.
Avoid contact with skin, eyes, and clothing.
Provide adequate ventilation.
This warning sign shall be printed both in English and in the pre­
dominant language of non-English-speaking workers, unless they are other­
3
wise trained and informed of the hazardous areas. All illiterate workers 
shall receive such training.
Section 4 - Personal Protective Equipment
(a) Protective Clothing
(1) Chemical safety goggles, face shields, or safety 
glasses with side shields shall be provided by the employer and shall be 
worn in any operation in which xylene may splash into the eyes.
(2) Appropriate protective clothing, including gloves, 
aprons, suits, boots, or face shields, shall be worn where needed to 
prevent repeated or prolonged skin contact.
(b) Respiratory Protection
(1) Engineering controls shall be used wherever feasible to 
maintain xylene concentrations below the prescribed limits. Such control 
equipment shall be sparkproof. Compliance with the permissible exposure 
limit may not be achieved by the use of respirators except:
(A) During the time period necessary to install or 
test the required engineering controls.
(B) For nonroutine operations such as a brief 
exposure to concentrations in excess of the permissible exposure limit as a 
result of maintenance or repair activities.
(C) During emergencies when air concentrations of 
xylene may exceed the permissible limit.
(2) When a respirator is permitted by paragraph (b)(1) of 
this Section, it shall be selected and used pursuant to the following 
requirements:
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(A) For the purpose of determining the type of 
respirator to be used, the employer shall measure, when possible, the 
atmospheric concentration of xylene in the workplace initially and 
thereafter whenever process, worksite, climate, or control changes occur 
which are likely to increase the xylene concentrations; this requirement 
shall not apply when only atmosphere-supplying positive pressure 
respirators will be used. The employer shall ensure that no worker is 
being exposed to xylene in excess of the standard because of improper 
respirator selection, fit, use, or maintenance.
(B) A respiratory protection program meeting the 
requirements of 29 CFR 1910.134 as amended shall be established and 
enforced by the employer.
(C) The employer shall provide respirators in 
accordance with Table 1-1 below and shall ensure that the employee uses the 
respirator provided.
(D) Respiratory protective devices described in 
Table 1-1 shall be those approved under the provisions of 30 CFR 11 as 
amended.
(E) Respirators specified for use in higher concen­
trations of xylene may be used in atmospheres of lower concentrations.
(F) The employer shall ensure that respirators are 
adequately cleaned, and that employees are instructed on the use of 
respirators assigned to them, and on how to test for leakage.
(G) Where an emergency may develop which could 
result in employee injury from overexposure to xylene, the employer shall 
provide respiratory protection as listed in Table 1-1.
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TABLE 1-1
RESPIRATOR SELECTION GUIDE FOR PROTECTION AGAINST XYLENE
Multiples of 
TWA Limit
Less than lOx
Less than 50x
Less than lOOx
Respirator Type
lOOx or more 
CAUTION!
The lower explosive 
limit is approximately
11,000 ppm
Unknown concentra­
tion
Escape
Chemical cartridge respirator with full face- 
piece and organic vapor cartridge(s).
Gas mask (full facepiece) with a chin-style 
organic vapor canister.
(1) Gas mask (full facepiece) with front or back 
mounted organic vapor canister.
(2) Type C supplied air respirator with a full 
facepiece operated in the demand (negative 
pressure) mode.
(3) Type C supplied air respirator with a full 
facepiece operated in the pressure-demand 
(positive pressure) or continuous flow mode.
(4) Self-contained breathing apparatus with a 
full facepiece operated in the demand 
(negative pressure) mode.
(5) Combination Type C supplied air respirator 
with full facepiece operated in the demand 
(negative pressure) or continuous flow mode 
and an auxiliary self-contained air supply 
operated in the demand (negative pressure) mode.
(1) Self-contained breathing apparatus with a 
full facepiece operated in the pressure-demand 
(positive pressure) mode.
(2) Combination Type C supplied air respirator with 
full facepiece operated in the pressure-demand 
(positive pressure) or continuous flow mode and 
an auxiliary self-contained air supply operated 
in the pressure-demand (positive pressure) mode.
Self-contained breathing apparatus with a 
full facepiece operated in the pressure-demand 
(positive pressure) mode.
(1) Gas mask (full facepiece) with chin style
or front or back mounted organic vapor canister.
(2) Self-contained breathing apparatus with full 
facepiece operating either in the demand 
(negative pressure) or pressure demand (positive 
pressure) mode.
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(a) Each employee exposed to xylene shall be informed at the
beginning of his employment or assignment to a xylene area of the hazards,
relevant symptoms, appropriate emergency procedures, and proper conditions 
and precautions for safe use or exposure. Each employee shall be 
instructed as to the availability of such information which shall be kept 
on file. Information kept on file shall include that prescribed in (b) 
below and shall be accessible to the worker at each place of employment 
where xylene is involved in unit processes and operations.
(b) Information as specified in Appendix III shall be recorded on
US Department of Labor Form OSHA-20, "Material Safety Data Sheet," or on a 
similar form approved by the Occupational Safety and Health Administration, 
US Department of Labor.
Section 6 - Work Practices
(a) Emergency Procedures
For all work areas in which there is a reasonable potential for 
emergencies, procedures as specified below, as well as any other procedures 
appropriate for a specific operation or process, shall be formulated in 
advance and employees shall be instructed in their implementation.
(1) Procedures shall include prearranged plans for 
obtaining emergency medical care and for necessary transportation of 
injured workers.
(2) Firefighting procedures shall be established and 
implemented. These shall include procedures for emergencies involving 
release of xylene vapor. In case of fire, xylene sources shall be shut off
Section 5 - Informing Employees of Hazards from Xylene
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or removed. Containers shall be removed or cooled with water spray. 
Chemical foam, carbon dioxide, or dry chemicals should be used for fighting 
xylene fires, and proper respiratory protection and protective clothing 
shall be worn.
(3) Approved eye, skin, and respiratory protection as 
specified in Section 4 shall be used by personnel essential to emergency 
operations.
(4) Nonessential employees shall be evacuated from exposure 
areas during emergencies. Perimeters of areas of hazardous exposures shall 
be delineated, posted, and secured.
(5) Personnel properly trained in the procedures and 
adequately protected against the attendant hazards shall shut off sources 
of xylene, clean up spills, and immediately repair leaks.
(b) Engineering controls such as process enclosure or local 
exhaust ventilation shall be used to maintain xylene concentrations within 
the recommended environmental limits. All such control equipment shall be 
sparkproof. Ventilation systems shall be designed to prevent the accum­
ulation or recirculation of xylene in the workplace and to effectively 
remove xylene from the breathing zones of exposed workmen. Exhaust 
ventilation systems discharging to outside air must conform with applicable 
local, state, and federal air pollution regulations. Ventilation systems 
shall be subject to regular preventive maintenance and cleaning to ensure 
maximum effectiveness, which shall be verified by periodic airflow 
measurements.
(c) Containers of xylene shall be kept tightly closed at all times 
when not in use. Containers shall be stored in accordance with the
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provisions of 29 CFR 1910, and shall be protected from heat, corrosion, 
mechanical damage, and sources of ignition.
(d) Washing of hands, equipment, or structures with xylene shall 
be prohibited.
(e) Any spills of xylene shall be promptly cleaned up.
(f) Prior to maintenance work, sources of xylene and xylene vapor
shall be eliminated to the extent feasible. If concentrations below the 
workplace air limit cannot be assured, respiratory protective equipment 
shall be used during such maintenance work.
(g) All metal dispensing containers shall be properly grounded.
Section 7 - Sanitation
(a) Food Facilities
Food preparation, dispensing (including vending machines), and eating 
should be prohibited in xylene work areas.
(b) Smoking
Smoking shall not be permitted in areas where xylene is used, 
transferred, stored, or manufactured.
Section 8 - Monitoring and Recordkeeping
Workroom areas shall not be considered to have xylene exposure if 
environmental levels, as determined on the basis of a professional indus­
trial hygiene survey or by the judgment of the compliance officer, do not 
exceed half of the recommended time-weighted average limit. Records of 
these surveys, including the basis for concluding that air levels are at or
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below half of the time-weighted average limit, shall be maintained until a 
new survey is conducted. Surveys shall be repeated when any process change 
indicates a need for réévaluation or at the judgment of the compliance 
officer. Requirements set forth below apply to areas in which there is 
xylene exposure.
Employers shall maintain records of environmental exposures to xylene 
based upon the following sampling and recording schedules:
(a) In all monitoring, samples representative of the exposure in 
the breathing zone of employees shall be collected. An adequate number of 
samples shall be collected to permit construction of a time-weighted 
average (TWA) exposure for every operation or process. The minimum number 
of representative TWA determinations for an operation or process shall be 
based on the number of workers exposed as provided in Table 1-2.
TABLE 1-2 
SAMPLING SCHEDULE
Number of
Number of Employees Exposed TWA Determinations
1-20 50% of the total 
number of workers
21-100 10 plus 25% of the excess 
over 20 workers
over 100 30 plus 5% of the excess 
over 100 workers
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(b) The first environmental samples shall be completed within 6 
months of the promulgation of a standard incorporating these recommenda­
tions.
(c) Environmental samples shall be taken within 30 days after 
installation of a new process or process change.
(d) Samples shall be collected at least quarterly in accordance 
with Appendix I for the evaluation of the work environment with respect to 
the recommended standard.
(e) Environmental monitoring of an operation or process shall be 
repeated at 30-day intervals when the xylene concentration has been found 
to exceed the recommended environmental standard. In such cases, suitable 
controls shall be initiated and monitoring shall continue at 30-day 
intervals until two consecutive surveys indicate the adequacy of these 
controls.
(f) Sampling records shall be maintained so that exposure 
information is available for individual employees and shall indicate the 
type of personal protective devices, if any, in use at the time of 
sampling. Each employee shall be able to obtain information on his own 
environmental exposure.
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II. INTRODUCTION
This report presents the criteria and the recommended standard based
thereon which were prepared to meet the need for preventing occupational
diseases arising from exposure to xylene. The criteria document fulfills
the responsibility of the Secretary of Health, Education, and Welfare, 
under Section 20(a)(3) of the Occupational Safety and Health Act of 1970 to 
"...develop criteria dealing with toxic materials and harmful physical 
agents and substances which will describe...exposure levels at which no 
employee will suffer impaired health or functional capacities or diminished 
life expectancy as a result of his work experience."
The National Institute for Occupational Safety and Health (NIOSH), 
after a review of data and consultation with others, formalized a system 
for the development of criteria upon which standards can be established to 
protect the health of workers from exposure to hazardous chemical and 
physical agents. It should be pointed out that any recommended criteria 
for a standard should enable management and labor to develop better 
engineering controls resulting in more healthful work practices and should 
not be used as a final goal.
These criteria for a standard for xylene are part of a continuing 
series of criteria developed by NIOSH. The proposed standard applies only 
to the processing, manufacture, use of, or other occupational exposure to 
xylene as applicable under the Occupational Safety and Health Act of 1970. 
The standard was not designed for the population-at-large, and any 
extrapolation beyond occupational exposures is not warranted. It is 
intended to (1) protect against development of systemic effects, and
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against local effects on the skin and eyes, (2) be measurable by techniques 
that are valid, reproducible, and available to industry and governmental 
agencies, and (3) be attainable with existing technology.
For many years, myelotoxicity (toxicity to the blood and blood- 
forming organs) has been attributed to xylene, primarily because of the 
close structural similarity which exists between xylene and benzene and the 
established effects of benzene on the blood and blood-forming organs. 
Xylene has been contaminated frequently with benzene. Current scientific 
evidence obtained from human and animal studies indicates that alkylation 
of the benzene ring, such as exists with xylene (dimethylbenzene), results 
in a loss of these blood effects. Benzene appears to be unique among the 
monocyclic aromatic hydrocarbons in these myelotoxic properties. 
Therefore, the major problem of xylene toxicity concerns its narcotic 
effects on workers, causing symptoms and signs such as muscular weakness, 
incoordination, and mental confusion which may pose a risk to both the 
worker and others.
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III. BIOLOGIC EFFECTS OF EXPOSURE
Extent of Exposure
Xylene, C6H4(CH3)2, (formula weight 106.16), also called dimethyl- 
benzene or xylol, exists in 3 isomeric forms: 1,2 (ortho); 1,3 (meta);
and 1,4 (para). The more important physical properties of these isomers 
are presented in Table X-l. [1]
Commercial xylene is produced both from petroleum and from coal tar. 
A typical petroleum product contains approximately 20% o-xylene, 44% m- 
xylene, 20% p-xylene, and 15% ethylbenzene. Xylene from coal tar generally 
consists of 10-15% ortho-, 45-70% meta-, about 23% para-, and 6-10% 
ethylbenzene. Commercial xylenes may also contain small amounts of 
toluene, trimethylbenzene, phenol, thiophene, pyridine, and nonaromatic 
hydrocarbons. [2,3] The possibility that commercial xylene may also 
contain benzene should not be ignored.
Total US xylene production in 1971 was 612,325,000 gallons, an 
increase of 13.9% over 1970. [4] Of this total, 609,419,000 gallons were 
from petroleum. Production from coke ovens has decreased rapidly in recent 
years (35.4% from 1970-1971) and totaled only 2,906,000 gallons in 1971. 
The US Tariff Commission report [4] did not include data reported by tar 
distillers because publication would have disclosed operations of 
individual companies.
Xylene can be easily chlorinated, sulfonated, or nitrated. [5] It is 
used as a solvent for some gums and resins, castor and linseed oils, 
rubber, and dibenzyl cellulose. [6] It is a constituent of paint, lacquers 
and varnishes, [5,6] inks, dyes, adhesives and cements, and cleaning fluids
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[7]; it is also an additive in gasoline. [5-7] In the chemical industry it 
is used as a starting material for xylidines [5] and in the production of 
phthalic and terephthalic acids. [2,6] Other uses are in the manufacture 
of quartz crystal oscillators, hydrogen peroxide, perfumes, and insect 
repellents, [8] in the leather industry, in coating and impregnation of 
fabric and paper, and as a carrier in the production of epoxy resins. [2]
NIOSH estimates that approximately 140,000 workers are potentially 
exposed to xylene in the United States.
Historical Reports
Many early reports of xylene exposures involved exposure not to pure 
xylene but to mixed aromatic hydrocarbons. For example, in 1929 Stocke [9] 
reported that, although the term "xylene" was used in the occupational 
medical literature of the time, he found that the solvent called "xylene" 
in the intaglio printing industry might be pure xylene, pure toluene, a 
mixture of these, or a mixture containing benzene and paraffin hydrocar­
bons. Stocke examined approximately 40 workers exposed to these mixed 
solvents and observed symptoms of overexposure: headaches, nausea,
feelings of drunkenness, and reduced alcohol tolerance. In 10 of these, 
selected because they were the most severely affected, there was no anemia, 
but Stocke did report a relative lymphocytosis. To explain the reduced 
alcohol tolerance, he hypothesized that alcohol facilitated the diffusion 
of xylene (and toluene) in the body, and in particular expedited their 
entry into the lipids of the central nervous system.
In 1931 Nelken [10] examined 399 intaglio printers and 276 other 
printers not exposed to xylene. Relative lymphocytosis was observed in 29%
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of the intaglio printers and in 23.7% of the nonintaglio printers. An 
apparently significant difference in the incidence of leukopenia was 
observed, with 18.55% of the intaglio printers having a leukocyte count 
below 5,800, 15.03% below 5,500, and 9.29% below 5,000 compared to 13.64%, 
8.18%, and 3.63%, respectively, among the nonintaglio printers. Nelken 
considered this evidence of poisoning caused by "xylene (or toluene and 
benzene)."
In the same year Rosenthal-Deussen [11] described the experience of 
20 workers who were exposed to unknown concentrations of vapor of a 
commercial solvent, consisting of 35% benzene and its homologs, principally 
xylene. The major constituent(s) was not identified. Workers were exposed 
for 1-6 days while painting the inside of a tank that was not ventilated 
properly. Of the 20 workers exposed, 15 were reported as manifesting 
urinary abnormalities, among other signs and symptoms. There were 2 cases 
of anuria, 1 of which was fatal. In 13 cases the urine was described as 
"coffee-brown" in color. These included the 2 cases of anuria. In 2 other 
cases the urine was described as being red. With the limited environmental 
data available, it is impossible to say what role, if any, xylene may have 
played in the etiology of these disorders.
Hirsch [12] in 1932 investigated conditions in a print shop after 2 
of its workers died of valvular heart disease. Suspecting benzene 
poisoning because 1 of the deceased workers was anemic and the other had 
aplastic anemia, Hirsch examined 34 workers. Despite the fact that some 
thinners contained up to 29% benzene and toluene, Hirsch concluded that 
xylene was responsible for the anemia observed because xylene predominated 
(up to 87%) in the solvents and thinners used. Overall, he observed a
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moderate degree of anemia and relative lymphocytosis, but the latter was 
thought not to be necessarily occupationally related. Increases in urinary 
urobilin and urobilinogen were seen in 18 of 34 workers, with a very marked
increase in 3 of them. Such an increase (ie, in the last 3 cases) may be
regarded as an indication of liver damage. A majority of the workers were 
hypotensive. Radiography revealed pathological alterations of cardiac 
outline and size in 50% of the subjects, with dilatation of the aorta
present in the majority of the abnormals. Hirsch attributed these
phenomena to the "vasodilatory effect of xylene." Nineteen of the 34 
subjects were also anemic with hemoglobin levels of below 95% Autenreith in 
5 subjects, and a red cell count below 5 million/cu mm in 15 subjects. The 
observed hypotension might have been partly secondary to this anemia. Two 
years later in 1934, Verhoogen [13] also reported a fatal case of aplastic 
anemia and extreme leukopenia in a printer. Although he gave no details as 
to exposure, Verhoogen stated that the anemia was due to xylene exposure in 
a print shop. De Oliveira [14] in 1936 described a similar fatality due to 
aplastic anemia, but like Veerhoogen, [13] he failed to give any details 
concerning exposure except to state that the individual was exposed to 
xylene in the printing industry.
In 1935 Glibert [15] published 6 case reports involving pseudoperni- 
cious anemia and aplastic anemia which he ascribed to xylene exposure in 
the printing industry. The very imprecise meaning of the term "xylene" at 
that time was demonstrated by Glibert when he stated that the "commercial 
xylenes" used in the printing industry showed a variable composition, with 
"yellow or light xylene" being pure benzene with no trace of xylene, "green 
or dark xylene" being pure xylene, and some other xylenes actually being
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toluene with 15% benzene. Obviously, the term xylene was applied to a
variety of solvents, and even what was considered to be pure xylene must
have been contaminated if it was green or dark in color, since pure xylene 
is colorless.
A detailed study of occupational disease associated with exposure to 
solvents in the printing industry was conducted in this country by
Greenburg et al [16] in 1939. In this report toxicity was attributed to 
benzene, but the report provides an insight into the mixed nature of
solvents in use at that time. In this study, benzene in the ink solvents 
and thinners ranged from 10-80% and other volatile solvents present 
included toluene, xylene, methylethyl ketone, petroleum naphtha, ethyl, 
butyl, and amyl acetate, and butyl and amyl alcohol. Thus, one must 
question the accuracy of those papers which reported "xylene" exposure in 
the printing industry through the 1940's. In most cases the thinners used 
probably consisted of a mixture of volatile solvents. Xylene probably was 
one of these, but benzene was almost certainly present as well.
Effects on Humans
In 1943 Nelson et al [17] investigated sensory response to 16 
industrial solvent vapors by exposing "an average number of ten persons, of 
mixed sexes," to metered concentrations of solvent vapors for a period of 
3-5 minutes. Based on the subjective responses of test subjects, xylene at 
200 ppm was reported to cause irritation of the eyes, nose, and throat in a 
majority of those exposed. A majority also estimated that 100 ppm would be 
a satisfactory 8-hour exposure level. The authors did not report the 
lowest concentration which was irritating to any subject, or which any
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subject estimated to be satisfactory for 8 hours. In comparison, toluene 
caused irritation of the eyes and throat in the majority at 300 ppm and 
most estimated 200 ppm as satisfactory for an 8-hour exposure.
In 1966 May [18] estimated the odor thresholds of 37 organic 
solvents, one of which was xylene. After measured volumes of solvent were 
vaporized in an evacuated 10-liter bottle, air was introduced and 
volunteers smelled the air at the mouth of the bottle. For xylene the odor 
threshold was reported as 20 ppm, with the odor of 40 ppm reported as 
distinctly noticeable. The odor threshold for toluene was reported as 40 
ppm, with 70 ppm distinctly noticeable.
Carpenter et al [19] exposed 6 human volunteers for 10 seconds to 
xylene in the following sequence: 60.0, 0.0, 6.0, 0.6, 0.6, 6.0, 60.0, and
0.0 mg/cu m (these concentrations were estimated from the metered concen­
trations, based on previous analytical measurement data; 0.0 represents 
controls). This resulted in a total of 12 exposures at each level. Xylene 
was detected 12 times at 60.0 mg/cu m (about 14 ppm) and 8 times at 6.0 
mg/cu m (1.4 ppm), but was not detected at the 2 lower concentrations. 
Based on these results, the most probable odor threshold was estimated to 
be 4.5 mg/cu m, or about 1.0 ppm.
Volunteers were also exposed [19] to measured xylene concentrations 
of 460, 1,000, and 2,000 mg/cu m (about 105, 230, and 460 ppm). The 15- 
minute exposures were limited to 1 a day to prevent buildup of symptoms. 
The odor of xylene was detected at each concentration by all subjects, and 
olfactory fatigue was reported by 3 subjects at each concentration but all 
reported full recovery within 10 minutes after the exposure ended. These 
and other effects are summarized in Table X-2. According to Carpenter et
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al, [19] all of these effects were minor. The "tears" were described as 
increased wetness of the eyes rather than actual tearing, the dizziness was 
characterized as slight lightheadedness without loss of equilibrium or 
coordination, and the subject reporting throat irritation was not positive 
of the sensation. The authors concluded that 1.0 mg/liter (230 ppm) should 
not be objectionable to most people.
Dutkiewicz and Tyras [20] described experiments with 10 volunteers in 
which a known quantity of xylene was kept in contact with the skin for a 
measured length of time, and the residual xylene was then calculated. In 
this way the absorption of liquid xylene through the skin was estimated to 
be at the rate of 4.5-9.6 mg/sq cm/hr.
In 1965 Gusev [21] studied the effects on human volunteers of low 
concentrations of xylene (also benzene and toluene). In 18 subjects, the 
odor threshold increased in the sequence xylene, toluene, benzene. For 
xylene, the minimal perceptible concentration was 0.6-1.9 mg/cu m (about 
0.14-0.44 ppm), and the maximal imperceptible concentration was 0.4-1.4
mg/cu m (about 0.09-0.32 ppm). To investigate the effects of each solvent 
on the electrical activity of the cerebral cortex, Gusev exposed 4 subjects
at concentrations of solvent that were imperceptible by odor. The 4
subjects chosen were those with the lowest olfactory threshold for each
solvent. Benzene and toluene were found to increase the electric 
potentials of the cerebral cortex, while xylene caused a marked inhibition 
of electrical activity. The threshold for these cortical effects by xylene 
was 0.32 mg/cu m (0.07 ppm), and 0.21 mg/cu m (0.05 ppm) was subliminal. 
Therefore 0.2 mg/cu m was recommended by this author as the "maximum 
permissible one-time" atmospheric concentration. Further investigations
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are necessary to validate these findings.
While painting the inside of a tower with a paint containing 80%
xylene and 20% methylglycolacetate, 8 workmen experienced headache,
vertigo, gastric discomfort, dryness of the throat, and feelings of slight 
drunkenness. [22] Forced ventilation could not be used, so the painters 
were instructed to go outside for 10 minutes every half-hour. While
cycling home from work, an 18-year-old who had been "working with paints”
for 2 months suddenly felt weak and dizzy. After reaching home he had an 
epileptiform seizure lasting about 20 minutes. He was sent to the hospital 
where he suffered another seizure of much shorter duration. When examined, 
all reflexes were normal as was an electroencephalogram. Because there had 
been an instance of possibly epileptic aura in the patient at age 14, 
Goldie [22] suggested that organic solvents might provoke seizures in 
patients with latent epilepsy. No follow-up information on this patient 
was given.
Glass [23] described the symptoms of a man who was intermittently 
exposed to solvent vapors over a period of 2 months. He was examined after 
an acute episode of vomiting and giddiness at the end of a day's work. His 
appetite was poor for the following week. The solvent was 75% xylene with 
25% ethylbenzene, methylethylbenzenes, and trimethylbenzenes. Concentra­
tions of xylene in air were measured and found to be as high as 270-350 ppm 
at head level. However, the worker probably was intermittently exposed to 
much higher concentrations for 12- to 15-minute periods while he was 
bending over into the paint vessels he cleaned with a solvent-soaked rag.
Morley et al [24] in 1970 reported an incident in which 3 painters in 
a shipbuilding yard were exposed to xylene vapor in a confined space. The
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concentration of xylene was later estimated to have been 10,000 ppm. After 
an unknown time interval, 2 of the 3 men became unconscious and therefore 
remained in the xylene atmosphere until they were discovered 18.5 hours 
later. The third man had left the tank for a period of 3 hours and then 
returned and also became unconscious. One of the men died shortly after 
discovery. At autopsy, apart from severe lung congestion with focal intra- 
alveolar hemorrhage and acute pulmonary edema, the victim was found to have 
petechial hemorrhages in the brain and evidence of anoxic neuronal damage. 
The other 2 men were mentally confused for some time after recovering 
consciousness, and both had retrograde amnesia for events preceding their 
loss of consciousness. There was evidence of severe impairment of renal 
function (a temporary severe rise in blood urea, and fall in endogenous 
creatinine clearance) in 1 case, but the kidneys had largely recovered by 
the 15th day after exposure. Both nonfatal cases showed what was inter­
preted as evidence of hepatic impairment (elevation of serum transaminase 
levels after 48 hours in 1 case to over 50 and in the other to over 100 
international units, but enzyme levels then fell to within normal limits).
In 1957 Ghislandi and Fabiani [25] reported an incident of accidental 
ingestion of a "small amount" of liquid paint thinner composed of 90% 
xylene and toluene, with xylene predominating. The impurities were several 
acetates, but these were not identified. The day after ingestion, the 
urine had a specific gravity of 1.055, was positive to Fehling's test for 
dextrose in the urine, and contained urobilinogen. There was serological 
evidence (abnormal sulfobromphthalein retention) of a toxic hepatitis, but 
total recovery took place within 20 days. In the opinion of these authors, 
it could not be assumed that similar liver damage would necessarily arise
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from the inhalation of xylene vapor, but they emphasized the need for liver 
function testing in cases of ingestion.
Joyner and Pegues [26] in 1961 described an outbreak of upper 
respiratory irritation with evidence of "a mild nephrotoxic action" in all 
of 6 men who became ill (out of a total of 8 exposed) while demolishing 
some epoxy-resin concrete. Substantial amounts of xylene were detected by 
infrared and mass spectrometric analyses of decomposition products of the 
concrete material and the odor of xylene was present during the demolition 
process. The urinary findings indicative of kidney damage were albumin­
uria, microhematuria, and pyuria in all 6 cases.
In 1956 Schmid [27] reviewed earlier reports of corneal disease in 
workers exposed to volatile solvents and discussed his own observations in 
furniture polishers. He reported that workers suffered eye irritation and 
photophobia primarily in the morning, but that these symptoms abated after 
a few hours of work. Slit lamp examination revealed minute vacuoles in the 
corneal epithelium, but the cornea healed completely in a few days with no 
scars remaining, even in workers who were frequently affected. Whenever 
the lesion occurred, workers had been exposed to a number of volatile 
solvents, including xylene, toluene, butyl acetate, butanol, ethylene 
alcohol, and ethylene acetate at unknown concentrations.
When Schmid [27] exposed 6 humans to xylene, toluene, methyl acetate, 
ethylene acetate, and butyl acetate evaporating from saturated filter 
paper, toluene was the most irritating to the eyes and xylene was the least 
irritating. Apparently, the exposures were not sufficient to produce 
corneal vacuolization in any of the humans.
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Matthaus [28] described a furniture polisher who complained of 
burning, sensation of pressure, sensation of a foreign body, and dazzling 
in both eyes, with slight limitation of vision. On examination both eyes 
showed marked conjunctival injection, but the corneas were clear and 
sparkling. However, under high magnification a large number of minute, 
dewdrop-like vacuoles were seen in the deeper layers of the corneal 
epithelium opposite the palpebral fissure. The little vesicles were 
particularly concentrated in the pupillary and subcentral zones. Matthaus 
was amazed that the patient had only slight visual disturbance. The 
subjective eye complaints had developed within 2-3 days from the time he 
started working with a new lacquer solvent. Seven fellow workers were also 
involved but had only slight subjective eye problems. However, on 
ophthalmic examination, 4 of these had similar alterations in their corneas 
and 3 had isolated vacuole formation, despite mild subjective complaints. 
The cases were followed up and the corneal changes fully recovered leaving 
no scars after removal from exposure for an average of 8-11 days. Gas 
chromatographic analysis of the lacquer solvent showed it to be "practi­
cally pure" xylene. Contamination by toluene and benzene "was so minor 
that it could be ignored." Whether this effect is totally reversible on 
intermittent exposure or whether it may eventually lead to permanent damage 
is not known. Unfortunately no environmental data were offered as to the 
concentration of the xylene vapor to which these workers were exposed.
A 1957 Polish paper [29] reported troubles of heart function and 
electrocardiographic changes indicative of cardiac muscle damage in a 17- 
year-old worker who was overcome by xylene vapor. He had been exposed for 
an unspecified time at an unstated concentration and was unconscious for 3
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hours. According to the authors, this complication was "characteristic" of 
the susceptibility of juveniles to the action of aromatic hydrocarbons, but 
they did not document this characteristic susceptibility.
In 1965 Michon [30] reported a survey of the menstrual history of 500 
Polish women, aged 20-40 years, working in a shoe factory in an atmosphere 
contaminated by benzene, toluene, and xylene at unstated concentrations. 
The aromatic hydrocarbon concentrations were said to be within the Polish 
permissible limits (31 ppm for benzene, 67 ppm for toluene, and 58 ppm for 
xylene). Compared with 100 women not working in shoe production, the 
subjects exposed to the aromatic hydrocarbons showed some increased 
intensity and duration of the menstrual flow, but no alteration in 
menstrual rhythm. It is impossible to say which of the contaminants in the 
air was responsible for this influence upon menstruation, or to evaluate 
the significance of such menstrual disturbance.
Kucera [31] investigated the incidence of spinal malformations 
(sacrococcygeal agenesis, or caudal regression syndrome), in all human 
malformations recorded in Czechoslovakia from 1959-1966. In over 1,500,000 
live and stillborn infants, more than 20,000 were malformed. Skeletal 
malformations included the caudal regression syndrome in 9 of these 
infants. Five of the 9 mothers involved had been exposed to fat solvents 
(xylene in 1 case) during their pregnancy. After observing teratogenic 
effects among chick embryos exposed to xylene vapors (discussed in Animal 
Toxicity), Kucera concluded that fat solvents, including xylene, may have a 
teratogenic effect causing caudal agenesis in man. However, his data are 
not adequate to support such a contention.
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In 1956 Giammarinaro [32] reported a fatal case of what was described 
as osteosclerotic anemia with aplastic myelosis in a 46-year-old typog­
rapher. Giammarinaro gave no details of the patient's exposure except to
state that he "worked since youth as a printer and had constant contacts 
with xylene." Without knowing the purity of the xylene or the concentra­
tion to which the man was exposed, the author considered both the bone 
condition and the aplastic anemia to be independent effects resulting from 
xylene intoxication. However, as suggested by Browning [2] in her review 
of this report, an alternate and reasonable explanation of the case is that 
the anemia was secondary to idiopathic osteosclerosis.
Lachnit and Reimer [33] described 2 fatal cases of panmyelopathy. 
One was in a 20-year-old girl who had been employed 1 year in a textile 
factory where she used an adhesive containing 27% toluene and xylene with 
some esters and benzene. During pregnancy she developed severe anemia, 
leukopenia, and thrombocytopenia. The bone marrow was generally aplastic. 
She died 6 weeks after the birth of a healthy child. After her death, air 
samples collected in the workplace revealed 8 ppm benzene and 11.1 ppm
toluene, but these apparently represented an improvement over conditions 
prevailing during the woman's employment. No xylene concentrations were 
reported. In a second case, a man who had worked as a printer for 30 years
was possibly acutely overexposed when a fire burned 40 liters of xylene.
His health deteriorated thereafter and he died from aplastic anemia 1 year 
later. In an examination approximately 8 years before his death, the blood 
picture was essentially normal, but because his printing career had begun 
in 1922 there no doubt was a history of benzene exposure.
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Epidemiologic Studies
Lob [34] in 1952 published a study of 19 photogravure workers, in­
cluding 2 women, who had been exposed to ink-diluent vapors for periods 
ranging from several months to 21 years. In the 4 cases selected as being 
clearly pathological, the workers had been exposed for 7, 9 (a woman with 
intermittent exposure), 18, and 20 years. No further correlation was made 
between the observed abnormalities and either the degree or length of 
exposure. Overall results included hemoglobin levels of 70-85% in 11 
subjects, including 1 of the women. The total white cell count was
reported to be below 5,000/cu mm in 11 cases, below 4,000 in 1 case, and 
below 3,000 in 2 cases; whether this refers to a total of 11 or 14 cases is 
not clear. Granulocytes were below 3,000/cu mm in 9 cases, below 2,000 in 
4 cases, and below 1,500 in 2 cases; whether this refers to 9 or 15 cases 
is unclear. Bone marrow examinations were also performed and mild general 
hypoplasia was found in 2 cases, severe general hypoplasia in 2 cases, and 
aplasia in 2 cases. In the erythropoietic series there was evidence of 
some hyperplasia in 7 cases and of hypoplasia in 1 case, with inhibition of 
maturation in 14 cases. In 15 cases the myeloid series showed inhibition 
of maturation. These results are suggestive of mild myelotoxicity, but 
once more the nature of the exposure is suspect. The ink solvent in use 
was described as a mixture of toluene and xylene with "no more than a 
minimal trace of benzene." The author stated that benzene was not used in 
that print shop in "appreciable quantity" except for 1 month, 5 years 
before this paper was published. Because of the nature of photogravure 
work and the previous experience in printing normally required, prior 
exposure to solvents had undoubtedly occurred and it seems reasonable to
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Sukhanova et al [35] studied 45 young to middle-aged men who manufac­
tured xylene from gasoline. Employment ranged from 6 months to 5 years. 
Xylene vapor in the work atmosphere was considered to present the chief 
hazard, although other hydrocarbons such as gasoline were also present. 
The xylene concentrations ranged from 1.5-4 times the MAC in 35-40% of the 
samples taken, and the remainder of the air samples were below the MAC. 
The MAC for xylene in the USSR at that time was 50 mg/cu m (about 10 ppm). 
[36] Therefore, the air levels were below 50 mg/cu m in 60-65% of the 
samples but ranged as high as 200 mg/cu m (approximately 45 ppm). On being 
questioned, "approximately one-third" of the workers complained of head­
aches, irritability, insomnia, tachycardia, and dyspepsia. In 9 workers 
(20%) nervous system alterations of the type of "neurasthenic or astheno- 
autonomic syndromes" were established, and "autonomic-vascular dysfunction" 
was observed in 6 (13%). There were no other significant symptoms, and 
these potentially psychosomatic clinical findings were not compared with 
the incidence in a control population. The amount of phenols excreted in 
the urine was higher than normal in all cases. There were no changes in 
the erythrocyte, reticulocyte, or thrombocyte counts or in hemoglobin. 
Both the glycogen and peroxidase contents of neutrophils were found to be 
decreased in comparison with controls, and the decrease became more 
pronounced with increased duration of exposure. The authors inferred from 
these cytochemical changes a disturbance of the functional capacity of the 
leukocytes and predicted an eventual disturbance of immunologic processes.
suggest that there had been benzene exposure.
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Animal Toxicity
Chassevant and Garnier [37] observed in 1903 that toluene, ethyl- 
benzene, and benzene, in the order of decreasing toxicity, were more toxic 
than xylene when administered in one intraperitoneal dose to guinea pigs. 
The toxic (probably meaning lethal) doses of the xylene isomers were 1.20 
g/kg for p-xylene, 1.43 g/kg for m-xylene, and 1.98 g/kg for o-xylene. The 
toxic doses for toluene, ethylbenzene, and benzene were 0.44, 0.57, and
0.66 g/kg, respectively.
Batchelor [38] injected rats intraperitoneally and reported lethal 
doses of 2.0-2.5 cc/kg for xylene, 1.75-2.0 cc/kg for toluene, and 1.5-1.75 
cc/kg for benzene. Xylene and toluene at doses up to 0.75 cc/kg produced 
no signs except apathy, but benzene at doses as low as 0.25 cc/kg produced 
tremor and muscular twitchings. None of these solvents had an appreciable 
effect on the blood counts in animals that survived the acute toxic 
effects.
In 1928 Smyth and Smyth [39] exposed "at least 3" guinea pigs to m- 
xylene vapor, initially at 450 ppm. One animal died the first day and the 
others were prostrate, so the exposure concentration was reduced to 300 ppm 
for the remainder of a total of 64 exposures. The first 2 weeks, exposures 
were made daily. Thereafter, animals were exposed for 4 hours a day, 6 
days a week. There was "not much evidence of definite harm," although at 
necropsy slight degeneration of the liver and inflammation of the lungs 
were noted. The experiment was repeated later at 300 ppm for 58 exposures, 
again with few effects. Guinea pigs also were exposed to toluene and 
suffered no serious effects after 35 exposures at 1,000 ppm, suggesting 
that for this species xylene was the more toxic solvent.
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Lazarew [40] reported lethal concentrations for white mice of 30 
mg/liter (6,900 ppm) for o-xylene, 50 mg/liter (11,500 ppm) for m-xylene, 
and 15-35 mg/liter (3,450-8,050 ppm) for p-xylene. The lethal concen­
tration of toluene was 30-35 mg/liter (8,010-9,345 ppm). These data were 
incorrectly cited by Browning [2] and in a Report of the International 
Labour Office, [41] probably because of transposition of figures from 
Lazarew's table. Narcotic effects were noted [40] at concentrations of 15- 
20 mg/liter (3,450-4,600 ppm) for o-, 10-15 mg/liter (2,300-3,450 ppm) for 
m-, and 10 mg/liter (2,300 ppm) for p-xylene. Exposure to m-xylene at a 
concentration of 15 mg/liter (3,450 ppm) resulted in the abolition of 
(undescribed) reflexes in the mice.
Inhalation experiments with rats and mice were described by Cameron 
et al. [42] Rats and mice in groups of 10 were exposed at various concen­
trations of toluene and to each xylene isomer. Mice appeared to be more 
sensitive than rats, with some mice dying after 24-hour exposures at 
concentrations of 2,010 ppm of m-xylene or 3,062 ppm of o-xylene. Mice 
survived 24-hour exposures at 4,912 ppm of p-xylene and at 6,100 ppm of 
toluene.
By subcutaneous injection, [42] the lethal dose in rats and mice was
5-10 cc/kg of toluene, p- or m-xylene, while the lethal dose of o-xylene
was about half as large. The lethal dose for each was about half as much
when injected intraperitoneally, but the relative toxicities remained the 
same. Although the number of animals used was not given, the authors 
concluded that "no definite effect" was produced when rabbits received 1-ml 
subcutaneous injections of o-, m-, or p-xylene on 3 consecutive days. All 
variations observed were considered well within the limits of normality.
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Wolf et al [A3] found that xylene had greater acute oral toxicity to 
rats than either toluene or benzene. The LD50 for xylene was 4.3 g/kg 
while the LD50s for toluene and benzene were 7.0 and 5.6 g/kg, respec­
tively. Xylene and benzene caused more necrosis and were more irritating 
to the skin of rabbits than toluene. As indicated by the appearance, body 
weight, and behavior of the rabbits, these solvents apparently were not 
absorbed through the skin in acutely toxic amounts. Two drops of xylene 
instilled into rabbits' eyes produced slight conjunctival irritation with 
very slight and transient corneal injury, but Wolf et al [43] gave few 
details of the changes observed in the eyes of the rabbits.
Temporary corneal effects were also noted by Schmid, [27] who 
described the formation of vacuoles in the corneas of cats exposed to 
xylene vapor. The vacuoles reportedly disappeared within a day when 
exposure to xylene was stopped. The vacuoles were similar to those 
reported by Schmid [27] and Matthaus [28] in the eyes of furniture 
polishers exposed to xylene.
In a more recent study [CP Carpenter, DL Geary, written communica­
tion, April 1974] corneal vacuolization was not observed in the eyes of 
adult male New Zealand rabbits exposed to a mixture of xylene isomers. 
Xylene was instilled in the right eye of a rabbit once daily for 2 days and 
then 3 times daily on 3 days. Although the lids were swollen and partially 
denuded, the cornea appeared normal at all times on fluorescein staining 
and on examination by hand slit lamp and ophthalmoscope. To examine the 
possibility that a metabolic product might cause vacuolization, 2 rabbits 
were given 8 ml/kg per os and both died within 3 days. When eyes were 
examined with the hand slit lamp and ophthalmoscope, there was no evidence
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of vacuolization prior to or following death. One rabbit was exposed at a 
metered concentration of 60 mg/liter (13,800 ppm) for 3 hours (the actual 
concentration probably was 7,000-8,000 ppm). The rabbit was prostrate
after 30 minutes and the left eyelid apparently was held open against the 
side of the exposure chamber. Consequently, the right eye was normal but 
the left eye appeared rough and dry. The entire left cornea stained with 
fluorescein and on the following day appeared dull to the unaided eye. 
However, both corneas were normal within 1 week and no corneal
vacuolization was seen in either eye at any time.
According to Schumacher and Grandjean, [44] the LD50s by intraperi- 
toneal injection in mice were 1.15 ml/kg for benzene, 1.3 ml/kg for 
toluene, 1.4 ml/kg for a 2:1 mixture of toluene and xylene, and 1.8 ml/kg 
for xylene. In inhalation experiments with rats, the time in seconds of 
exposure to produce narcotic effects was uniformly greater for xylene than 
for toluene and benzene. The starting concentration in each case was
15,000 ppm. Benzene was rated in a group of substances with strong
affinity for the nervous system, while toluene was in an intermediate
group, and xylene was in the group with the least affinity for the central 
nervous system.
Hine and Zuidema [45] tested the toxicity of 10 hydrocarbon solvents 
representative of those used in industry. One of these was a mixture of 8- 
carbon aromatic solvents (the 3 xylene isomers and ethylbenzene). This 
sample contained at least 98% aromatics and had a boiling range of 138-141 
C. The LD50 for rats when injected intragastrically was 10.0 ml/kg. By 
inhalation the 4-hour LC50 was 6,350 ppm, with all deaths occurring during 
exposure. Survivors were comatose but recovered shortly after removal from
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the chamber. Rabbits were used to test for primary skin irritation, eye
irritation, percutaneous toxicity, and for irritation after repeated skin 
applications. The xylene mixture was rated as moderately irritating and 
practically nontoxic by percutaneous absorption. Overall, the xylene
mixture was considered by these authors to be relatively harmless under
these experimental conditions.
In 1940 Rigdon [46] postulated an increase in the permeability of 
capillaries in rabbit skin, based on the localization of dyes, antitoxins, 
and carbon particles following cutaneous application of xylene. In a
second paper, [47] he showed that intravenously injected staphylococci 
localized and concentrated in areas of skin treated with xylene. 
Subsequently Rigdon [48] demonstrated the localization of antibodies in 
areas pretreated with xylene. Finally, in 1949 Rigdon [49] reported that 
antihistamines did not modify the xylene localization effects, which 
therefore might be due to a "variation in the absorptive ability of the 
tissue cells" in addition to increased capillary permeability.
Falck and Moller [50] applied solvents and ultraviolet light to the 
shaved skin of rabbits. There was a highly significant increase in the 
water content of skin treated with xylene. A decrease in the catechol­
amines was also noted in the skin.
In 1960 Mikiska [51] and Mikiskova [52] described a technique for 
evaluating narcotic effects by measuring the threshold of excitability of 
the cerebral motor cortex. Stimulation electrodes were attached to guinea 
pigs, and threshold determinations were made before and after 
intraperitoneal injection of benzene, toluene, or xylene. Each hydrocarbon 
increased the excitation threshold, with the most significant elevation
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caused by xylene. No change followed Injection of physiological saline. 
Clonic muscle contractions and tremors were observed in some cases after 
the injection of xylene and in all cases after benzene, but not after 
toluene was injected. This apparently represented a second phase of 
action, which was accompanied by increased cortical excitability. Often 
the tremors and muscle contractions were observed during the narcotic 
state, suggesting to Mikiskova [52] that parts of the central nervous 
system were not subject to the same inhibition.
Battig and Grandjean [53] tested the effects of xylene exposure on 
avoidance conditioning in 6 experimental and 6 control rats. The 
conditioning stimulus was a phone buzzer, followed by an electrical shock 
which the rats could avoid by moving into a safe part of the cage. 
Experimental animals were exposed to xylene at initial concentrations of 
800 ppm. Concentrations fell to 550-750 ppm in the first 2.5 hours, after 
which no further decrease was observed. Avoidance response tests began 2 
hours after xylene exposure began. The authors observed no clear effect by 
xylene on any phase of the avoidance testing. There appeared to be no 
difference between test and control groups in acquiring the conditioned 
response, and in the consolidation phase the xylene-exposed animals were 
reported to have an insignificantly higher avoidance response rate. In the 
extinction phase, the exposed rats had a slightly slower extinction of the 
avoidance response when the buzzer was not followed by the electric shock.
Desi et al [54] investigated central nervous system dysfunction as 
evidenced by maze learning ability in rats given xylene. Untrained rats 
were injected subcutaneously either with xylene or with physiologic saline 
at a dose of 0.05 ml/100 g body weight. From the beginning, the xylene-
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injected rats ran the maze much more slowly than the controls, and their 
running times declined at a slower rate. Although test scores fluctuated, 
the differences between test and control groups were highly significantly 
different in every instance. Pretrained rats were subcutaneously injected 
with physiologic saline (0.05 ml/100 g) or with xylene at doses of 0.02, 
0.05, or 0.10 ml/100 g. Ataxia and death in experimental animals given 
xylene at 0.10 ml/100 g led to discontinuation of experiments at that
level. The rate of weight gain was reduced compared to controls and the 
running times for the xylene groups were longer, but the differences were 
not statistically significant. Thus, the ability to learn a maze seemed to 
suffer more than the ability to perform trained behavior.
Investigating the role of irritation in carcinogenesis, Berenblum 
[55] exposed white mice to 3,4-benzpyrene with xylene, and to xylene alone 
as a control. Berenblum concluded that the addition of xylene did not 
produce a significant difference in the yield of tumors. He also concluded 
that xylene was probably not carcinogenic, although one minute tumor (which 
regressed) was observed in a control animal treated with xylene. Xylene 
applied at a concentration which produced irritation similar to that 
produced by croton oil showed no evidence of being co-carcinogenic.
In experiments by Pound and Withers, [56] mice received daily right- 
side subcutaneous injections of 0.25 ml of xylene from 1-6 days prior to 
injection of 25 mg urethane. Seven days following urethane injection, and 
once a week thereafter, the entire back of each mouse was painted with 0.25 
ml of croton oil in acetone (0.5% solution). The numbers of survivors and 
the number and location of papillomata were counted each week for 20 weeks. 
Xylene showed some toxicity, as 8 mice died within 2 weeks. Groups of mice
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treated with xylene gave significantly (p = 0.005) higher yields of left­
sided tumors than mice treated with acetic acid, trichloroacetic acid, 
turpentine, or scarification. The relative severity of changes in the skin 
produced by the various irritant substances correlated with the increases 
in tumor yield observed in animals treated with these substances. The 
authors concluded that, in addition to a local influence, xylene and some 
other substances "appeared to have a general effect that influenced the 
tumor yields." Pound [57] reviewed this work and commented that the
augmenting effect was not related to carcinogenic or promoting properties 
but to the inflammation and hyperplasia produced in the skin. This seems 
to be a more reasonable explanation.
In 1970, Pound [58] described further experiments using ultraviolet 
light to attempt to initiate tumor formation in mice. Single short 
exposures did not produce tumors, but tumors developed when the exposure 
was followed by application of croton oil. Ultraviolet light apparently 
was acting as an initiator. If the skin of experimental mice was 
pretreated with xylene, acetic acid, or croton oil before irradiation, then 
the number of tumors increased. Pound concluded [58] that cells which had 
been induced to proliferate were more susceptible to induction of tumors by 
ultraviolet light than normal cells.
Experiments by Jellinek were reported by Kucera in 1968. [31] The 
possible implication of fat solvents as etiological agents in human sacral 
agenesis led to experiments in which chick embryos were exposed at an 
unstated concentration of xylene vapor for 60-240 minutes. A significant 
increase in malformations and mortalities was observed, and this correlated 
positively with the length of exposure to xylene. Younger chick embryos
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vere more susceptible. The author concluded that xylene had a teratogenic 
effect. [31] In view of the results of Kucera's survey of human 
sacrococcygeal agenesis, this seems to be an effect, if real, of fat 
solvents in general, rather than of xylene in particular.
To investigate possible embryotoxic or teratogenic effects, Krotov 
and Chebotar' [59] exposed pregnant white rats to dimethyIterephthalate, 
"paratoluic methylate (PT-ether)" (apparently this was methyl (p-toluic 
acid) ether), or p-xylene vapor during gestation. Twenty-nine rats were 
exposed to p-xylene at 500 mg/cu m (115 ppm) for 20 days, 24 hours a day. 
On the 20th day of pregnancy, the experimental and 17 control rats were 
killed. A count was made of corpora lutea in the ovaries, the number of 
implantation points, and the number of living and dead fetuses. Fetuses 
were examined grossly and microscopically for abnormalities. Experimental 
rats experienced significantly greater preimplantation mortality (32.1%) 
than controls (11.3%). Postimplantation mortality was also higher (38.9% 
vs 4.8%). No teratogenic effects were observed, the only malformed fetus 
(shortened tail and adactylia of the 5th toe of a rear foot) being 1 of 110 
living fetuses in the "PT-ether” group.
Kashin et al [60] in 1968 exposed 9 chinchilla rabbits at 200 mg/cu m 
(46 ppm) for 2 hours daily, and a second group of 9 was exposed at 50 mg/cu 
m (12 ppm) for 4 hours daily, both groups for 10—12 months. They suggested 
3 periods of change due to long-term action by small concentrations of 
xylene. The first, or compensation period of 1—3 months, was characterized 
by increases in hemoglobin content, erythrocytes and leukocytes, increases 
in common proteins and especially in gamma globulins, increased activity of 
blood acetylcholinesterase, and increased excretion of 17-ketosteroids in
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urine. At the same time, inhibitory effects were exhibited by weight loss 
and by decreased immunological response. A second or normalization phase 
then occurred during the 4th-8th months of exposure. The authors 
interpreted the changes to indicate weakening of adrenal cortex functions, 
disturbance of intermediary metabolism, and decreased immunobiological 
activity, and they concluded that these reflected overstraining of defense 
mechanisms and adaptation systems. The final or physiological decompensa­
tion phase occurred with decreases in the. activity of several systems. The 
authors concluded [60] that more pronounced changes were caused by a long 
exposure to a low concentration of xylene than by shorter exposure to a 
higher concentration. They considered a concentration of 50 mg/cu m (12 
ppm) with 4 hours daily exposure to be an unacceptable exposure limit. It 
is difficult to evaluate the significance of these findings in light of an 
inadequate description of the experiment, including results in control 
animals.
Batchelor [38] exposed rats to benzene, toluene, xylene, or high- 
flash naphtha by inhalation, subcutaneous injection, or intraperitoneal 
injection. This work was supported by the National Safety Council, who 
also published the results, [61] and it was reviewed and discussed by 
Winslow. [62] In the inhalation experiments, rats were exposed for 18-20 
hours a day at various concentrations of solvent vapor. Batchelor did not 
report analyzing the xylene for benzene contamination, but the boiling 
point of the xylene used was 139 C, suggesting that there probably was 
little benzene present. Of 4 rats exposed to xylene at 1,600 ppm, 1 died 
after 2 days and 1 after 4 days. The remaining 2 were removed after 2 days 
of exposure and recovered. [61] Initial signs of exposure were instability
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and incoordination with evidence of mucous membrane irritation. Narcosis 
prevented ingestion of food and water, leading to weight loss, anhydremia, 
and death. The white blood count was reduced by 27% in the rat that died 
after 4 days of exposure. There was no effect on the white count of rats 
exposed only 2 days. An increased red blood cell count was attributed to 
the anhydremia. Four rats exposed at 980 ppm for 7 days exhibited similar 
signs but narcosis did not result. The bone marrow and spleen were hyper­
plastic and kidneys showed acute congestion with moderate cloudy swelling 
but no signs of an acute nephritis. One rat had a 32% reduction in the 
white count. No signs of toxicity were observed in 8 rats exposed at 620 
ppm for 7 days, with the exception of a 30% reduction in the white count of 
1 rat. In contrast, benzene at high concentrations (1,000-2,440 ppm) did 
not produce narcosis and death, but after 6-7 days of exposure the rats' 
skeletal muscles became hypertonic and rats suffered clonic spasms and a 
spastic gait. This condition persisted for 3-4 days after exposure ended. 
Leukopenia and destruction of the bone marrow bordering on aplasia were 
observed after exposure at all benzene concentrations used (2,440, 1,035, 
815, and 460 ppm). [38,61,62]
Mixed in equal volumes of olive oil, the solvents were also injected 
subcutaneously. [38] Xylene was injected for 10 consecutive days at doses 
of 1 and 2 cc/kg. This resulted in slightly reduced activity and a 
transient reduction in the red blood cell count, but had no effect on the 
white blood cell count. At autopsy, the bone marrow was found to be hyper­
plastic, and mild necrosis of the liver and diffuse nephritis were seen. 
Benzene at a dose of 1 cc/kg caused a reduction in the white count to below 
2,000/cu mm after 4-21 daily injections. A reduction in the red blood cell
count appeared later, accompanied by bone marrow aplasia. General signs,
which appeared early and became progressively more severe as benzene 
injections continued, included apathy, extreme weight loss, great weakness, 
and tonic and clonic muscle contractions of the body and extremities.
In 1924 Woronow [63] reported experiments in which he injected 
rabbits subcutaneously twice daily with benzene in olive oil at a dose of 
1.5 ml (units are assumed since none were given in the article).
Leukopenia developed rapidly, and a leukocyte count of zero reportedly was 
observed after 9-11 days. When xylene in olive oil was injected subcutane- 
ously in the same dosage, the leukocyte count dropped in the first 4-5 days 
then rose markedly to 20,000-30,000 by the 9th or 10th day. The elevation 
was due primarily to increased numbers of monocytes and neutrophils. 
Myelocytes and juvenile forms were not observed. By the 5th day, the 
granules of neutrophils were reported to be exclusively basophilic, and 
monocytes reportedly began to show basophilic granulation. Bone marrow was 
hyperplastic. Similar results were observed after rabbits were injected 
with toluene. Cumene produced a less pronounced leukocytosis with a shift 
to the left. Woronow [63] concluded that the methyl groups acted on 
leukocytes and on the hematopoietic organs, and suggested that increasing
the number of methyl groups on the benzene ring produced changes
increasingly similar to myeloid leukemia, but it seems more likely that 
these changes in xylene-treated animals were a normal response to toxic 
insult.
Farber [64] in 1933 reported similar experiments that had been 
conducted to verify Woronow's [63] findings. After rabbits were 
subcutaneously injected twice daily with 1.5 ml xylene in olive oil, there
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was an immediate reduction in the white count, followed by an increase to 
about 60% above the initial values. No increases as high as those reported 
by Woronow were observed. Farber noted that the same initial drop in 
leukocytes occurred when a rabbit was injected with olive oil alone. The 
responses after xylene injections were summarized as a definite 
leukocytosis, a shift to the left, monocytosis, atypical cells in the 
granulocyte series (similar to a degeneration), disturbed red cell analysis 
(polychromasia and increased numbers of normoblasts), and hyperplasia of 
the bone marrow.
Because injection of xylene caused necrosis which led to the skin 
sloughing off in patches, Farber [64] exposed rabbits to xylene by 
inhalation to rule out effects due to irritation, infection, and necrosis. 
Rabbits were placed in a bell jar, with xylene evaporating from a filter 
paper, until they were unconscious. In this case there was no 
leukocytosis, shift to the left, or monocytosis. Changes in the red blood 
series were similar to those observed after injections, but were much less 
severe. The bone marrow was not hyperplastic. Farber therefore concluded 
that the skin irritation and severe inflammatory processes were responsible 
for the blood changes observed in the injection experiments. The 
possibility of benzene contamination is an additional factor that 
complicates the interpretation of these studies reported in 1929 by 
Woronow, [63] and in 1933 by Farber. [64]
Engelhardt [65] exposed cats and rabbits at xylene concentrations of 
10 mg/liter (2,300 ppm) and 25 mg/liter (5,750 ppm), and observed a 
reduction in the number of red blood cells and a pronounced leukocytosis. 
After cats and rabbits were injected with xylene, Engelhardt saw a distinct
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shift to the left and leukocytosis, but like Farber [64] he attributed 
these changes to local effects such as inflammation and necrosis at the 
injection site. Engelhardt concluded that toluene and xylene were less 
toxic than benzene.
Fabre et al [66] exposed rats and rabbits for 8 hours a day, 6 days a 
week to a benzene-free mixture of the xylene isomers. Six rabbits were
exposed at 5 mg/liter (1,150 ppm) for 40-55 days, and 12 rabbits and 9 rats
were exposed at 3 mg/liter (690 ppm) for 110-130 days. At 3 mg/liter there 
were no significant changes in the blood. At 5 mg/liter there were 
decreases in both red and white cells. At both concentrations of xylene 
the bone marrow was hyperplastic, but there was no tendency to aplasia. 
Microscopic examination revealed vascular congestion in the liver, kidney, 
heart, adrenals, lungs, and spleen of animals exposed at each
concentration. The renal lesions (chronic subacute glomerulonephritis) 
were observed after exposure at both concentrations and were considered the 
most important observations. Based on this observation, the authors 
recommended caution in the use of xylenes, and suggested that such effects 
in man would be indicated by an increase in blood urea and the appearance 
of albumin and blood in the urine.
In 1968, Speck and Moeschlin [67] were unable to demonstrate any 
myelotoxic effects in rabbits from toluene or xylene. Rabbits received 
toluene or xylene subcutaneously in doses of 300 mg/kg/day for 6 weeks or 
700 mg/kg/day for 9 weeks. Erythrocyte, reticulocyte, leukocyte, and 
thrombocyte counts were made twice weekly, and all values fluctuated within 
normal limits. Cytopenia was not induced in any cell type. Using 
tritiated methyl thymidine and autoradiographic techniques, the authors
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determined that neither toluene nor xylene affected DNA synthesis in the 
bone marrow. Earlier, similar experiments with benzene had resulted in 
aplastic anemia, and autoradiographic analysis had demonstrated arrested 
DNA synthesis in the bone marrow. [68,69] The authors suggested [67] that 
earlier reports of aplastic anemia caused by toluene or xylene could be 
attributed to benzene contamination, and stated that their results 
presented "a substantial argument for the lack of myelotoxicity of toluene 
and xylene."
In 1970, Jenkins et al [70] reported the results of long-term inhala­
tion studies of benzene, toluene, and o-xylene using rats, guinea pigs, 
monkeys, and dogs. Pre- and postexposure body weight, hematologic data, 
and mortalities were reported. Experiments with o-xylene were conducted at 
3,358 mg/cu m (770 ppm) and 337 mg/cu m (78 ppm), while studies with 
toluene were conducted at 4,095 mg/cu m (1,085 ppm) and 389 mg/cu m (105 
ppm). With benzene, exposure levels were 817 mg/cu m (255 ppm) and 98 
mg/cu m (30 ppm). At the higher concentration in each case, there were 30 
repeated exposures for 8 hours a day, 5 days a week, while at the lower 
concentration there was continuous exposure for 90 days. Animals were also 
continuously exposed to benzene at a concentration of 56 mg/cu m (17 ppm) 
for 127 days. At the end of the exposures, animals were killed and 
necropsied. Sections of heart, lung, liver, spleen, and kidney were taken 
from all species; sections of brain and spinal cord were obtained from dogs 
and monkeys for microscopic examination. Results of microscopic 
examinations were negative and no significant changes were noted in body 
weight or hematologic data. However, the authors reported only leukocyte 
counts rather than complete differential white blood counts and they did
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not examine the bone marrow, so these results are not negative evidence of 
benzene effects.
In 1974 Carpenter et al, [19] using a solvent sample containing 80.5% 
mixed xylenes (65.0% m-xylene) and 19.3% ethylbenzene, exposed male rats 
and dogs at measured concentrations of 3.5, 2.0, and 0.77 mg/liter (805, 
460, and 175 ppm) for 6 hours a day, 5 days a week for 13 weeks. Blood 
analyses (including hematocrit, total erythrocyte count, reticulocyte 
count, total and differential leukocyte counts, serum alkaline phosphatase, 
serum glutamic pyruvic transaminase, serum glutamic oxalacetic 
transaminase, and blood urea nitrogen) were determined initially, at 
intervals during exposure, and at the end of the exposure period. Rats 
were killed at intervals and all surviving rats and dogs were killed at the 
end of 65-66 exposure days. No gross or microscopic lesions were ascribed 
to inhalation of the mixed xylenes. Blood counts and blood analyses 
likewise did not differ significantly from baseline levels or from levels 
in unexposed controls.
Using serum ornithine carbamyl transferase (OCT) activity to screen 
for liver damage, DiVincenzo and Krasavage [71] injected guinea pigs 
intraperitoneally with organic solvents and collected blood samples 24 
hours later. In 117 control animals, serum OCT activity averaged 2.0 ± 1.6 
international units (IU), but after injection with 1,000 mg/kg of xylene, 
the OCT activity of 4 guinea pigs averaged 18.4 IU. At a dose of 2,000 
mg/kg, 3 of 4 animals died, and mean OCT activity was reported as 25.2 IU. 
As a positive control, carbon tetrachloride was administered in doses of 5- 
150 mg/kg. The OCT activity in the 5 mg/kg group was 3.8 IU, and in the 
other groups (25-150 mg/kg) ranged from 37.1-64.4 IU. Liver sections from
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each test animal were examined microscopically, and showed signs of lipid 
deposition in the hepatocytes at both xylene dosages, but no evidence with 
hematoxylin-eosin stain of hepatocellular damage.
Many of these studies of xylene have examined its toxicological
properties in comparison with those of benzene or toluene. Reports
regarding the relative toxicity of the isomers of xylene and toluene and 
benzene are conflicting. Smyth and Smyth [39] and Wolf et al [43]
published results suggesting that xylene was more toxic than toluene. The 
data of Chassevant and Garnier, [37] Batchelor, [38] and Schumacher and 
Grandjean [44] showed the opposite. The work of Lazarew [40] and of 
Cameron et al [42] indicated that toluene was less toxic than some but more 
toxic than other xylene isomers, but these papers did not agree in detail. 
No clear pattern emerges from these studies, and it is only possible to 
conclude that the acute toxicity of xylene is of the same order of
magnitude as that of toluene. This does not necessarily reflect the 
relative chronic toxicities.
Changes in the blood [38,64] and hyperplasia of the bone marrow 
[38,64,66] have been reported in animals injected subcutaneously with 
xylene. Leukocytosis and a reduced red count were reported in a 1935
inhalation study. [65] However, blood changes were not seen in 1 of these
older studies when the animals were exposed to xylene by inhalation, [64] 
and the author attributed, probably correctly, the blood changes seen after 
injection to the expected response to inflammatory processes. More recent 
studies have shown no blood changes after exposure by inhalation [19,66,70] 
or by injections. [67] In contrast, benzene has produced aplasia after
subcutaneous injection [68,69] and after inhalation. [38]
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Correlation of Exposure and Effect
Like most organic solvents xylene has irritant effects on the skin, 
[2,3,72] and on the mucous membranes, [24] including the conjunctiva [28] 
and respiratory tract. [24] Xylene also has narcotic effects on the 
central nervous system, [21,24] variable effects on the liver [12,24,25] 
and kidneys, [24,26] and rather nonspecific, probably irritant, effects on 
the gastrointestinal tract. [22,23] Questionable effects on the 
cardiovascular system [12,29] and female reproductive endocrine system [30] 
have been reported. In the past, xylene was thought to have significant 
deleterious effects on the bone marrow and hemopoietic system in general, 
[10,12-15] but in the light of more recent research, this appears doubtful.
[19,66,67,70] The better controlled studies of Speck and Hoeschlin [67-69] 
give strong support to the conclusion that xylene uncontaminated by benzene 
does not have such effects.
The narcotic and other effects of xylene at high concentrations were 
well established by the incident described by Morley et al. [24] Three 
painters working in the confined space of a ship's fuel tank were overcome 
by xylene vapor from the paint they were using, in which the solvent was 
90% xylene. The authors estimated that the xylene concentration had 
reached 10,000 ppm. It was not known how long it took the men to lose 
consciousness, because they were not found until 18.5 hours after they 
entered the tank. One died shortly after discovery and at autopsy showed 
pulmonary edema and intra-alveolar hemorrhages. The other 2 men survived 
and recovered completely in about 2 days. They both had temporary hepatic 
impairment (inferred from elevated serum transaminase levels) and 1 had 
evidence of temporary renal impairment (increased blood urea and reduced
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endogenous creatinine clearance).
Giddiness, anorexia, and an episode of vomiting were observed in a 
paint-pot cleaner who used a solvent containing 75% xylene (the remaining 
25% consisting of ethylbenzene, methylethylbenzenes, and trimethylben- 
zenes). [23] At head height above the paint-pots, the xylene concentration 
ranged from 60-100 ppm when the pots were cold but from 270-350 ppm when 
the pots were warm. It was believed that the worker was exposed frequently 
to an even higher level when he placed his head inside the warm pots during 
cleaning.
Nelson et al [17] exposed a group of volunteers, usually 10, of both 
sexes to various solvent vapors, including xylene, in an exposure chamber 
for 3-5 minutes. The subjects were questioned about the subjective effects 
of eye, nose, and throat irritation. They were also asked the highest
concentration which they considered satisfactory for an 8-hour exposure. 
The majority of subjects found a xylene concentration of 200 ppm irritating 
to eyes, nose, and throat and judged 100 ppm to be the highest
concentration subjectively satisfactory for an 8-hour exposure.
In a Soviet xylene extraction plant, xylene concentrations were below
50 mg/cu m (about 10 ppm) in 60-65% of the air samples taken, and ranged
from 75-200 mg/cu m (about 15-45 ppm) in the remaining samples. [35] 
Forty-five workers had been exposed for periods ranging from 5 months to 6 
years. [35] One-third of these workers complained of occasional headaches, 
insomnia, irritability, tachycardia, and dyspepsia. If any were made, 
similar observations were not reported for unexposed workers. What were 
called neurasthenic or asthenoautonomic syndromes were observed in 9 
workers (20%) and autonomic-vascular dysfunction (not further defined) was
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observed in 6 workers. Again there were no similar observations in a 
control group. The amount of phenols excreted in the urine was higher than 
normal in all cases (the actual amount and the "normal" were not given). 
Peripheral blood polymorphonuclear leukocytes had a decreased glycogen and 
peroxidase content, compared with unidentified controls. These decreases 
were more marked in those employed 3-5 years than in those employed 1-3 
years. The authors projected that such cytochemical changes might 
eventually lead to disturbance of the immunological processes.
In the first 30-40 years of this century a variety of blood changes, 
including aplastic and pseudopernicious anemia, were attributed to xylene 
exposure. [10,12-15] However, because the xylene of that era was 
contaminated with benzene and other hydrocarbons, [9,15,16] these reports 
can be regarded only as evidence that a health problem existed at that 
time. More recent studies that have reported blood changes in exposed 
workers have involved known exposure to benzene as well as xylene [33,34] 
or employment in a print shop during the time when benzene contamination of 
xylene was probable. [32-34] In animal experimentation, changes in the 
blood and bone marrow have been reported after injections of xylene [38,64] 
and in a 1935 study [65] after inhalation. More recent studies do not 
report blood changes after injections [67] or after exposure by inhalation,
[19,66,70] and studies [67-69] with good controls strongly support the 
conclusion that uncontaminated xylene does not have myelotoxic effects.
In 1950 Browning [73] called xylene "innocuous to the haematopoetic 
system." In a 1965 review, [2] she pointed out what she considered to be 
the dubious nature of practically all the reports of bone marrow effects 
since the exposures described were either admitted to involve concomitant
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exposure to benzene, or were suspected of involving significant amounts of 
benzene as a contaminant. In a series of papers reviewing available data 
and presenting his own results, Gerarde [3,72,74,75] reviewed the evidence 
and concluded that the myelotoxic properties of benzene were destroyed by 
alkylaticr. of s±.e benzene ring. Lehmann and Flury in 1943, [76] Johnstone 
and Miller in 1960, [77] and Lederer in 1972 [78] all expressed the view 
that there was little or no evidence that xylene was a myelotoxicant.
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IV. ENVIRONMENTAL DATA AND BIOLOGIC EVALUATION
Sampling and Analysis
Xylene can be directly measured in the field with a calibrated 
combustible gas indicator, [72,79] but the method is nonspecific, being 
subject to interference in the presence of other organic compounds. The 
same disadvantage applies to the interferometer. [1,72] Detector tubes 
also offer a rapid, simple procedure, but depend upon an estimation of the 
length of a stain produced in the tube or on the intensity of color 
produced. Unfortunately, detector tubes are not particularly accurate, and 
are also nonspecific, other aromatic hydrocarbons also producing colors. 
[80-82]
Collection in a bubbler containing sulfuric acid and formaldehyde has 
also been proposed, but this method is little more than semiquantitative. 
[83,84] Collection in a bubbler containing methanol with subsequent 
measurement by ultraviolet spectrophotometry has been described, [85] but 
has the disadvantage of requiring that the sampling unit be placed in dry 
ice to prevent evaporation. In addition, sampling of breathing zone 
exposures is more difficult with sampling devices containing liquids.
Silica gel has been used by a number of investigators to collect 
xylene vapor for laboratory analysis. [86-88] In the presence of water 
vapor, however, there may be considerable loss. Whitman and Johnston [89] 
reported that this problem could be overcome by the use of a molecular 
sieve prefilter.
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Plastic bags have also been used to collect xylene and other organic 
vapors. [90-92] Possible losses with time through reaction of the specific 
compound with the type of plastic used must be determined in advance.
Adsorption of xylene vapor on activated charcoal has been studied by 
a number of investigators. [93-95] Activated charcoal is the preferred 
sampling method since the xylene is not displaced by water vapor, as is the 
case with silica gel, and because it is a simpler, more convenient 
procedure than the use of plastic bags or bubblers. White et al [95] have 
defined the design of activated charcoal tubes suitable for sampling 
occupational exposures to xylene, and such tubes are commercially 
available. They reported average desorption efficiencies (percent xylene 
recovered from the charcoal) of 94% (range 91-96%) for 100 ppm 
concentrations of xylene sampled alone and 98% (range 97-100%) in the 
presence of 6 other organic vapors.
Various methods for analyzing the collected samples have been used, 
including colorimetric, [83,84] infrared analysis, [88] and ultraviolet 
spectrophotometry. [85,87,96] In recent years, however, gas chromatography 
has become the method of choice of most investigators for analysis of 
organic solvents. [86,88,89,93-95,97-99] Gas chromatography also offers 
suitable specificity and sensitivity. [89,93,95]
Appendices I and II present recommended methods for sampling and 
analyzing xylene. These include collection of personal samples, using 
charcoal tubes, desorption with carbon disulfide, and measurement with a 
gas chromatograph equipped with a flame ionization detector. [94,95,100] 
The sampling method has the advantages of using a small, portable sampling 
device and of involving no liquids. Analysis is by means of a quick
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instrumental method that can be used for the simultaneous analysis of 2 or 
more solvents in the same sample. Disadvantages include the fact that the 
amount of sample that can be collected is limited by the number of 
milligrams that the tube will hold before overloading, and the fact that 
volatile compounds can migrate to the backup section during storage before 
analysis. The precision of the method is limited by the reproducibility of 
the pressure drop across the charcoal tubes. Nevertheless, the accuracy of 
the overall sampling and analytical method is 10%. [100,101] Interferences 
are minimal, and most of those which do occur can be eliminated by altering 
chromatographic conditions.
Control of Exposure
Engineering design and work practices for xylene should have, as 
their main objectives, controlling vapor concentrations, minimizing skin 
contact, and preventing fires.
Closed systems, properly operated and maintained, should be used, 
where practicable, to achieve all 3 of these objectives. Where closed 
systems are not feasible, well-designed local exhaust ventilation should be 
provided. [6] Guidance for design can be found in Industrial Ventilation—  
A ¡Manual of Recommended Practice, [102] or more recent revisions, and in
'v
ANSI Z9.2-1971. [103] Exhaust air should not be recirculated, and should 
be scrubbed to prevent pollution of the outdoor air. Respiratory 
protective equipment is not an acceptable substitute for proper engineering 
controls, but should be available for emergency purposes, and for 
nonroutine maintenance and repair situations.
Sparkproof equipment in exhaust hoods, stands, booths, or similar
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arrangements should be employed where xylene-containing paints or lacquers 
are sprayed. Exposures should be minimized by isolating painting and 
drying areas.
Protective clothing should be worn wherever required to prevent skin 
contact. Equipment made of natural rubbers should be avoided since it is 
subject to solvent action by xylene. Neoprene or other materials resistant 
to xylene should be used for gloves, aprons, or other protective clothing. 
[8]
Xylene is a flammable liquid that vaporizes at normal temperature. 
At 25 C, the vapor pressures of the isomers range from 5.2 mm Hg for o- 
xylene to 8.6 mm Hg for p-xylene, and the lower explosive limit is 1.1% by 
volume. [1] The vapor can travel a considerable distance to a source of 
ignition and flash back. Ignition sources include open flames, chemical 
reactions, lightning, smoking, hot surfaces, radiant heat, and spontaneous 
combustion. Static electricity can also present a hazard. [81 All metal 
dispensing containers should be properly grounded when pouring.
Structures and operations should be designed with the objectives of 
reducing the possibilities of fires, and of limiting the size or spread of 
any which might occur. Storage of materials is also an important factor. 
Firefighting procedures should be developed in advance, and local fire 
departments, as well as plant employees, should be informed of the hazards 
involved. [8]
Biologic Evaluation
The first report on xylene metabolism apparently was that of 
Schultzen and Naunyn [104] in 1867. They demonstrated toluric acid (the
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glycine conjugate of toluic acid) in the urine of dogs and men after 
ingestion of xylene. In 1892, Curci [105] reported that xylenols were also 
formed as metabolites of xylenes. This was confirmed in 1914 by Filippi,
[106] who also showed that the ortho isomer had greatest chronic toxicity 
in the dog.
Bray et al [107] investigated the metabolism in rabbits of the xylene 
isomers, administered by stomach tube. They reported that all 3 isomers 
were primarily oxidized to the corresponding toluic acid (60%, 81%, and 88% 
of the administered dose, respectively, for o-, m-, and p-xylene). The o- 
toluic acid was excreted mainly unconjugated and as an ester glucuronide, 
with a small amount excreted as a glycine conjugate. The m- and p-toluic 
acids were excreted chiefly as glycine conjugates with only small amounts 
excreted free or conjugated with glucuronic acid. There was some evidence 
of hydroxylation: 6% of o- and 4% of m-xylene doses were excreted as
ethereal sulfate and 10-15% of the p-xylene dose was probably excreted as 
an ether glucuronide. Additionally, there was some evidence that p-xylene 
may have given rise to a xylenol.
In a later paper, Bray et al [108] presented additional data on the 
fate of xylenes and xylenols in the rabbit. They concluded that it seemed 
most likely that the phenolic material excreted after the administration of 
xylenes consisted mainly of xylenols, both free and conjugated. When the 
xylenols were administered directly to rabbits only small amounts of 
further oxidation or hydroxylation products were detected. The authors 
considered this evidence that the amount of the xylenols formed from the 
metabolism of xylene was probably very small.
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Fabre et al [109] administered pure xylene isomers to rabbits, rats, 
and guinea pigs by stomach tube. Their results confirmed the oxidation of 
each isomer to the corresponding toluic acid and indicated that the second 
methyl group resisted oxydation, since no phthalic acids were isolated. In 
the case of o- and p-xylene, the phenolic metabolites were identified as 
3,4-dimethylphenol (asymmetrical o-xylenol) and 2,5-dimethylphenol (p- 
xylenol), respectively. A xylenol metabolite of m-xylene was isolated but 
not identified.
Bakke and Scheline [110] administered each of the 3 xylene isomers to 
rats in an oral dose of 100 mg/kg body weight, and phenolic metabolites 
were quantitatively estimated in hydrolyzed urine samples by gas chromatog­
raphy. o-Xylene was metabolized to 3,4-dimethylphenol (0.1% of the dose) 
and to very small amounts of 2,3-dimethylphenol (approximately 0.03% of the 
dose). m-Xylene was metabolized to 2,4-methylphenol (0.9% of the dose), 
and p-xylene to 2,5-dimethylphenol (1.0% of the dose). In addition, 2- 
methyl benzyl alcohol was a metabolite of o-xylene. This had not been 
previously reported. This work confirmed the earlier work of Bray et al
[107] suggesting oxidation of a methyl group to give toluic acids as a 
major pathway for xylene. Bakke and Scheline [110] noted that the 
conversion of aromatic hydrocarbons to phenols by hydroxylation "is 
accompanied by an appreciable increase in acute toxicity," but they 
considered this of little importance because the metabolites occurred in 
small quantities which were partly eliminated as glucuronides and ethereal 
sulfates.
Fridlyand [111] injected guinea pigs and rats subcutaneously with 90 
mg doses of benzene, toluene, o-, m-, or p-xylene, then collected urine for
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analysis. According to Fridlyand, toluene and xylene were demethylated and 
phenol was formed. In rats, the quantity of phenol excreted was greatest 
after injection of benzene and decreased in the order p-xylene, toluene, m- 
xylene, and o-xylene. The relationship was the same for guinea pigs except 
that o- and m-xylene, in that order, resulted in the least phenol.
Recent quantitative inhalation experiments by Ogata et al [112] 
showed that 72% of absorbed m-xylene was excreted in the urine of male vol­
unteers as m-methylhippuric acid during and within 18 hours after the end 
of exposure. Attempting to relate excretion data to exposure levels, the 
authors found that total excretion during and for 18 hours after exposure 
was most accurate, followed by excretion rates (in mg methylhippuric 
acid/minute) during exposure. Least accurate but still useful were urine 
concentrations of methylhippuric acid, corrected to a specific gravity of
1.024, during the afternoon and morning exposure periods. Concentrations 
uncorrected for specific gravity were too variable to be of use.
Subjects were exposed in groups of 4 or 5 for 7 hours, with a 1-hour 
break after the 3rd hour, to m- or p-xylene at 100 ppm, or to m-xylene at 
200 ppm. [112] Urinary excretion of methylhippuric acid rose during 
exposure, peaking 6-7 hours after exposure began. The results are 
summarized in Table X-3. Based on these results, the authors proposed 
"screening levels" 2 standard deviations below the average excretion after 
exposure at 100 ppm. They suggested that if methylhippuric acid excretion 
by an exposed worker was above the screening level, it should be taken as 
evidence that the person might have been exposed above 100 ppm (according 
to their statistical interpretation, this would be true in 5% of the 
cases). Separate screening levels were given for samples taken in the
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morning and afternoon, as well as a screening level for the rate of 
excretion over a 7-hour exposure period. These proposed screening levels 
are given in Table X-4.
This report by Ogata et al [112] contains the only published data 
found by NIOSH that quantitatively correlate the urinary excretion of 
xylene metabolites with exposure levels. Unfortunately, this work was done 
using pure m- or p-xylene. Thus, there are no data correlating urinary 
excretion with o-xylene exposure, and the excretion resulting from exposure 
to mixed xylene isomers is unknown. If mixtures do not alter the relative 
metabolism and excretion of the isomers, it is possible that the excretion 
of, for example, m-methylhippuric acid could be used to compute total
xylene exposure based on the percentage composition of the mixture in use.
The suitability of this procedure has not been verified experimentally.
Ogata et al [113] also developed 2 analytical procedures for the
determination of m- and p-methylhippuric acid in urine, based on colored
azlactone formation. A silica gel method involved extraction of the 
methylhippuric acids with an ethyl ether/ethyl alcohol solution, drying 
with silica gel, and azlactone formation using p-dimethylaminobenzaldehyde 
in acetic anhydride. The azlactones were extracted with ethyl ether and 
the absorbance read at 460 nm. Standard solutions prepared by the same 
extraction procedure were applied to aqueous solutions of m- or p-dimethyl- 
aminobenzaldehyde reagent and gave a positive reaction with urea. However, 
the extraction procedure using ethyl ether/ethyl alcohol did not extract 
urea from urine. The sensitivity of this method was 4 Mg/ml urine. The 
other method, using benzenesulfonyl chloride, was less sensitive (20 Mg/ml 
urine), but was much simpler to use. The methylhippuric acids were
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extracted with ethyl acetate or ethyl ether/ethyl alcohol solution and the 
azlactones formed by reaction with benzenesulfonyl chloride in pyridine 
solution. The absorbance was then read at 380 nm against a pyridine- 
benzenesulfonyl chloride blank. Recoveries by both methods were 94-100%. 
Hippuric acid, a urinary metabolite of toluene, is also determined by both 
methods, but hippuric acid, m-, and p-methylhippuric acid can be separated 
by paper or thin-layer chromatography and then determined spectro- 
photometrically.
A more recent paper by Buchet and Lauwerys [114] described a gas 
chromatographic technique for the determination of both hippuric acid and 
m-methylhippuric acid in urine. Comparison indicated that this technique 
was as specific and as sensitive as that reported by Ogata et al, [113] but 
it was much more rapid. A known amount of heptadecanoic acid, as the 
internal standard, was added to urine before its extraction with ethyl 
acetate. After evaporation of the solvent, the acids were methylated with 
diazomethane and the residue was taken up in methanol and injected into the 
gas chromatograph. The ratio of the height of the m-methylhippuric acid 
peak to the height of the heptadecanoic acid peak was calculated and by 
reference to a calibration curve prepared in the same conditions the urine 
concentration of the acid was determined. This technique could 
simultaneously determine both hippuric and m-methylhippuric acid, but was 
not described in connection with the metabolites of o- and p-xylene. 
Therefore, while this method seems promising, its applicability to mixtures 
of o— , m-, and p-methylhippuric acid is unknown.
These reports indicate that the major metabolic pathway for xylene 
involves oxidation of a single methyl group followed by conjugation with
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glycine or glucuronic acid. [104,105,107,109,112] The relatively low 
toxicity of these major metabolites was cited in reviews by Laham [115] and 
Gerarde [75] as an explanation for the apparent lack of myelotoxicity on 
the part of xylene and other alkylbenzenes. In review articles, Browning, 
[2] Laham, [115] and Gerarde [75] have attributed the myelotoxicity of 
benzene to its phenolic metabolites. However, as pointed out in the recent 
NIOSH benzene criteria document, [116] the phenolic metabolites do not 
produce hematopoietic toxicity when administered directly. In any event, 
while some hydroxylation of xylene apparently occurs, [107-110] the amount 
of phenolic metabolites produced is small. [109,110]
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V. DEVELOPMENT OF STANDARD
Basis for Previous Standards
The earliest US standard for xylene appeared in a list of toxic 
limits published in 1943, [117] in which the value of 200 ppm was
recommended as a Maximum Allowable Concentration (MAC). In 1945 Cook, 
[118] in his then comprehensive list of recommended MACs, cited 200 ppm for 
xylene in all the states mentioned (California, Connecticut, Massachusetts,
New York, Oregon, Utah) as well as for the USPHS and the "American War
Standard." This MAC was established by analogy with toluene, but Cook 
commented that "xylene vapor is somewhat more irritating to the eyes than 
that of toluene and it is probable that a somewhat lower limit of exposures 
may be required to permit comfort of the worker." [118]
In 1946, the American Conference of Governmental Industrial 
Hygienists (ACGIH) recommended a MAC of 200 ppm for xylene. [119] In 1948 
the terminology was changed to Threshold Limit Value (TLV), but the level 
remained at 200 ppm. According to the 1962 documentation, [120] the 
effects of xylene were considered to be similar to those of toluene. The
200 ppm TLV was based on the report by Nelson et al [17] of irritation at
200 ppm and on the suggestion of Greenburg and Moskowitz. [121] In 1963,
the ACGIH for the first time added a "C" (ceiling) notation to a number of
TLVs, including that for xylene. [122] This 200 ppm ceiling remained in
effect until the TLV was changed to a time-weighted average (TWA) of 100
ppm, proposed in 1965 [123] and adopted in 1967. [124] The basis given in 
the 1966 [125] and 1971 [126] documentation was Gerarde's opinion [3] that 
100 ppm would be more acceptable from the standpoint of comfort and worker
performance, as well as the report by Nelson et al [17] of irritation at 
200 ppm. The current TLV remains a TWA of 100 ppm, except that in 1974 the
"Skin" notation was added, [127] which was intended to suggest the need to
prevent skin absorption.
In 1951 Elkins [128] listed the maximum allowable concentration 
(presumably for Massachusetts) as 150 ppm, based in part on the
concentration found to be irritating.
The American National Standards Institute (ANSI) [1] acceptable 
concentrations of xylene in 1971 were 100 ppm as an 8-hour TWA, 200 ppm as 
a ceiling, and 300 ppm as an acceptable maximum for a peak above the 
ceiling (not more than 30 minutes' duration and encountered not more than 
once a day). The TWA level was intended to prevent irritation, based on 
human experience as reported by Nelson et al. [17] The basis for the
ceiling level was also human experience [17] and a review by Gerarde. [3] 
No basis was given for the 300 ppm peak, but it was said that there would 
be no health damage, provided that such an exposure would not be 
encountered more than once a day, although irritation of the eyes, nose, 
and throat was expected.
A number of limits have been set by foreign countries. In 1968 the 
Joint I.L0/WH0 Committee on Occupational Health [36] compiled the 
recommendations (listed in Table X-5) from 11 countries and 6 states in the 
United States, with values ranging from 10-200 ppm (50-870 mg/cu m). No 
basis was given for any of these limits. According to Bardodej, [129] the 
Czechoslovakian MAC was established on the basis of experience showing that 
the mean MAC of 200 mg/cu m (45 ppm) posed no hazard of damage after long­
term exposure, and that the peak MAC of 1,000 mg/cu m (230 ppm) presented
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no risk of acute poisoning. Bardodej cited his own unpublished work 
showing no health damage after exposure at 200 mg/cu m, although there were 
"single complaints by employees about headache and loss of appetit (sic), 
in exceptional cases drowsiness...." He also reported that unacclimatized 
persons complained of slight irritation of the eyes and "airways."
The present federal standard for occupational exposure to xylene is 
100 ppm as a TWA. [29 CFR 1910.93, published in the Federal Register, vol 
39, June 27, 1974] This was based on the ACGIH TLV in 1968.
Basis for Recommended Environmental Standard
Xylene can have a narcotic effect, apparently at relatively high 
levels, but actual air concentrations have not been reported. Johnstone 
and Miller [77] speculated that workers would not voluntarily remain in 
such an atmosphere long enough for the symptoms to develop because of the 
irritating nature of xylene. While this may make narcosis less probable, 
Morley et al [24] reported 3 cases (1 of which was fatal) and Sikora and 
Gala [29] reported 1 case in which workers, who were not trapped and could 
have escaped, were overcome by xylene vapor. No atmospheric concentrations 
were reported, but Morley et al [24] estimated the air level had reached 
10,000 ppm. Glass [23] reported that a worker intermittently exposed for 2 
weeks at concentrations of 270-350 ppm, and probably at higher 
concentrations on occasion, developed giddiness and vomiting, followed by 
anorexia for 1 week.
Liver damage [24] and kidney damage [24,26] have been reported after 
inhalation of xylene and liver damage [25] after the accidental ingestion 
of a small amount of a xylene-toluene thinner. In all these cases,
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exposure was sufficient to cause unconsciousness [24] or illness, [25,26] 
but all those involved recovered fully. No published evidence was found of 
irreversible liver or kidney damage. Liver necrosis and diffuse nephritis 
have been reported after xylene was injected intraperitoneally in rats, and 
moderate cloudy swelling of the kidneys followed exposure by inhalation. 
[38] DiVincenzo and Krasavage [71] recently reported lipid deposition in 
the liver and increased serum OCT activity after xylene was injected 
intraperitoneally in guinea pigs.
There have been reports of reversible corneal vacuolization resulting 
from exposure to xylene [28] or xylene plus other volatile solvents [27] in 
the furniture polishing industry. Two investigators reported similar 
transient vacuolization when cats were exposed to xylene vapor [27] and
when xylene was instilled in the eyes of rabbits. [43] More recently, 
efforts to produce this effect failed [CP Carpenter, DL Geary, written 
communication, April 1974] when rabbits were exposed to xylene vapor, had 
xylene instilled in an eye, or were given xylene by intratracheal tube.
In the past, xylene was thought to be myelotoxic based on reports
that occupational exposures had led to leukopenia, [10] relative
lymphocytosis, [10,12] and aplastic anemia. [12-15] In animal studies, 
changes that have been reported include transitory leukopenia, [38] 
leukocytosis, [65] and hyperplasia of the bone marrow. [38,64,66] Aplasia 
of the bone marrow has not been reported after administration of xylene, 
but has followed benzene exposure. [38,68,69]
In all of the occupational exposures to xylene, concomitant benzene 
exposure was either known or suspected at some time in the individual's 
career. Since benzene is known to cause the kinds of blood dyscrasias
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reported, [116] the myelotoxicity can be attributed to benzene rather than 
xylene exposure. This conclusion is supported by 2 recent animal studies
[19,70] in which exposure to pure xylene did not produce significant 
hematologic changes in rats, dogs, guinea pigs, or monkeys, although 
benzene has induced aplasia in other animal studies. [38,68,69] On this 
basis, it is concluded that xylene is not myelotoxic when uncontaminated 
with substances such as benzene. This conclusion that xylene is not 
myelotoxic was also expressed in review articles by Browning, [2,73] 
Gerarde, [3,72,74,75] Johnstone and Miller, [77] Lederer, [78] and by 
Lehmann and Flury. [76]
Thus, the only well-documented effects which a xylene standard should 
protect against are the irritating and narcotizing properties of xylene. 
There are no data available from actual occupational exposures, but these 
effects have been investigated experimentally. One study [40] indicated 
that narcotic effects were observed in mice at concentrations over 2,000 
ppm, while another [42] reported that some mice died after a 24-hour 
exposure to m-xylene at a concentration of 2,010 ppm. For humans, only one 
report was found which associated possible narcotic effects with a known 
xylene concentration. One of 7 volunteers exposed at 1.0 mg/liter (230 
ppm) and 1 of 6 exposed at 2.0 mg/liter (460 ppm) [19] experienced slight 
lightheadness without loss of equilibrium or coordination at the end of the 
15-minute exposure period.
Estimates of the odor threshold for xylene range from 0.6 mg/cu m 
(0.14 ppm) [21] to 20 ppm. [18] Although there was a wide difference in 
the odor thresholds, these authors [18,21] both reported a lower threshold 
for xylene than for toluene. Similarly, Nelson et al [17] found that
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xylene was more irritating than toluene to the eyes and mucous membranes 
during a 3- to 5-minute exposure. Based on this brief exposure, these 
subjects estimated that 100 ppm would be satisfactory for an 8-hour 
exposure. Based on 15-minute exposures, Carpenter et al [19] concluded 
that 1.0 mg/liter (230 ppm) should not be objectionable to most people.
While there are no adequate data available with which to establish a
xylene limit, neither are there data which indicate any need to alter the 
existing federal limit of 100 ppm. However, this TWA limit does not 
restrict excursions so long as the 8-hour TWA limit is not exceeded. Such 
a restriction is needed for xylene not only because of its irritant 
properties, but also because as a central nervous system depressant, xylene 
might at briefly high concentrations affect attention, judgment, or per­
ception sufficiently that if an emergency were to occur the worker might 
not respond appropriately. The study by Carpenter et al [19] suggests the 
possibility of minimal narcotic effects at a xylene concentration of 230
ppm. Therefore, in addition to the 100 ppm TWA, NIOSH recommends a 10-
minute ceiling of 200 ppm for xylene.
It is recognized that many workers handle small amounts of xylene or 
work in situations where, regardless of the amount used, there is only 
negligible contact with the substance. Under these conditions, it should 
not be necessary to comply with many of the provisions of this recommended 
standard, which has been prepared primarily to protect worker health under 
more hazardous circumstances. Concern for worker health requires that pro­
tective measures be instituted below the enforceable limit to ensure that 
exposures stay below that limit. For these reasons, "exposure to xylene" 
has been defined as exposure above half the environmental limit, thereby
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delineating those work situations which do not require the expenditure of 
health resources, of environmental and medical monitoring, and associated 
recordkeeping. Half the environmental limit has been chosen on the basis 
of professional judgment rather than on quantitative data that delineate 
nonhazardous areas from areas in which a hazard may exist. However, 
because of nonrespiratory hazards such as those resulting from skin 
irritation or eye contact, it is recommended that appropriate work 
practices and protective measures be required regardless of the air 
concentration.
The absence of data either in support of or in opposition to the 
existing limit of 100 ppm (or the prior ACGIH TLV of 200 ppm) apparently is 
due to the fact that no epidemiological studies have been attempted. While 
exposures to a pure solvent are rare, some effort is needed to describe 
what effects, if any, result from occupational exposures under current 
conditions. Some investigators have suggested effects on the liver, 
[12,24,25] the kidney, [24,26] the cardiovascular system, [12,29] and the 
gastrointestinal tract [23] after inhalation of xylene vapor. Effects on 
these organs and systems should be investigated to confirm or deny any 
involvement of xylene. Additionally, studies should be conducted to 
investigate the possibility of interaction between xylene and alcohol. 
Earlier reports [27,28] of corneal vacuolization were not confirmed by a 
recent animal study [19] but workers exposed to xylene should be examined 
to verify that no hazard exists for them. Although the recommended 
standard should prevent any narcotizing effects, including impaired 
judgment or reaction time, studies are needed for confirmation.
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The sampling and analytical methods presented in Appendices I and II 
are based on those described by White et al, [95] Kupel and White, [130] 
and in Method No. 127 of the Physical and Chemical Analysis Branch of 
NIOSH. [100]
VII. APPENDIX I
SAMPLING FOR XYLENE
Atmospheric Sampling
Breathing zone samples representative of the individual worker's
exposure shall be collected. A description of sampling location and
conditions, equipment used, time and rate of sampling, and any other
pertinent information shall be recorded at the time of sample collection.
Enough samples shall be collected to permit calculation of a time-weighted 
average (TWA) exposure for every operation or location in which there is 
exposure to xylene.
(a) Equipment
The sampling train consists of a charcoal tube and vacuum pump.
(1) Charcoal tubes: Glass tubes, with both ends flame-
sealed, 7-cm long with a 6-mm OD and a 4-mm ID, containing 2 sections of 
20/40 mesh activated charcoal separated by a 2-mm portion of polyurethane 
foam. The primary section contains 100 mg of charcoal, the backup section, 
50 mg. A 3-mm portion of polyurethane foam is placed between the outlet 
end of the tube and backup section. A plug of glass wool is placed in 
front of the primary section. The pressure drop across the tube must be
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less than 1 inch of mercury at a flowrate of 1 liter/min. Tubes with the 
above specifications are commercially available.
(2) Pump: A battery-operated pump, complete with clip for
attachment to the worker's belt, capable of operation at 1 liter/min or 
less.
(b) Calibration
Since the accuracy of an analysis can be no greater than the accuracy 
of the volume of air which is measured, the accurate calibration of a 
sampling pump is essential to the correct interpretation of the volume 
indicated. The frequency of calibration is dependent on the use, care, and 
handling to which the pump is subjected. Pumps should also be recalibrated 
if they have been misused or if they have just been repaired or received 
from a manufacturer. If the pump receives hard usage, more frequent 
calibration may be necessary. Regardless of use, maintenance and calibra­
tion should be performed on a regular schedule and records of these kept.
Ordinarily, pumps should be calibrated in the laboratory both before 
they are used in the field and after they have been used to collect a large 
number of field samples. The accuracy of calibration is dependent on the 
type of instrument used as a reference. The choice of calibration instru­
ment will depend largely upon where the calibration is to be performed. 
For laboratory testing, primary standards such as a spirometer or 
soapbubble meter are recommended, although other standard calibrating 
instruments such as a wet test meter or dry gas meter can be used. The 
actual setups will be similar for all instruments.
Instructions for calibration with the soapbubble meter follow. If 
another calibration device is selected, equivalent procedures should be
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used. The calibration setup for personal sampling pumps with a charcoal 
tube is shown in Figure X-l. Since the flowrate given by a pump is 
dependent on the pressure drop of the sampling device, in this case a 
charcoal tube, the pump must be calibrated while operating with a 
representative charcoal tube in line.
(1) The voltage of the pump battery is checked with a
voltmeter to assure adequate voltage for calibration. The battery is
charged if necessary.
(2) The tips of a charcoal tube are broken to produce
openings of at least 2 mm in diameter.
(3) The sampling train is assembled as shown in Figure X-l.
(4) The pump is turned on and the inside of the soapbubble
meter is moistened by immersing the buret in the soap solution and drawing 
bubbles up the inside until they are able to travel the entire buret length 
without bursting.
(5) The pump rotameter is adjusted to provide the desired
flowrate.
(6) The water manometer is checked to insure that the
pressure drop across the sampling train does not exceed 13 inches of water 
at 1 liter/min or 2.5 inches of water at 200 ml/min.
(7) A soapbubble is started up the buret and the time it 
takes the bubble to move from one calibration mark to another is measured 
with a stopwatch.
(8) The procedure in (7) above is repeated at least twice,
the results averaged, and the flowrate calculated by dividing the volume 
between the preselected marks by the time required for the soapbubble to
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traverse the distance. If, for the pump being calibrated, the volume of 
air sampled is calculated as the product of the number of strokes times a 
stroke factor (given in units of volume/stroke), the stroke factor is the 
quotient of the volume between the 2 preselected marks divided by the
number of strokes.
(9) Data for the calibration include the volume measured,
elapsed time or number of strokes, pressure drop, air temperature,
atmospheric pressure, serial number of the pump, date, and name of the 
person performing the calibration.
(c) Sampling Procedure
(1) Both ends of the charcoal tube are broken to provide
openings of at least 2 mm, which is half the ID of the tube. A smaller 
opening causes a limiting orifice effect which reduces the flow through the 
tube. The smaller section of charcoal in the tube is used as a backup 
section and therefore is placed nearest the sampling pump. Tubing is used 
to connect the back of the tube to the pump, but tubing must never be put 
in front of the charcoal tube. The tube is supported in a vertical 
position in the worker's breathing zone.
(2) A maximum of 15 liters of air is sampled at a flowrate 
of 50-1,000 ml/min. For the determination of ceiling concentrations the 
sampling time is 10 minutes. For the determination of 8-hour time-weighted 
average concentrations 2 4-hour or 4 2-hour samples are suggested.
(3) The temperature and pressure of the atmosphere being 
sampled is measured and recorded.
(4) One charcoal tube is treated in the same manner as the 
sample tubes (break, seal, ship) with the exception that no air is drawn
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through it. This tube serves as a blank.
(5) Immediately after sampling, charcoal tubes are capped 
with plastic caps. Under no circumstances should rubber caps be used. To 
minimize breakage during transport, capped tubes should be tightly packed 
in a shipping container. Bulk samples and charcoal tubes should be shipped 
separately.
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VIII. APPENDIX II 
ANALYTICAL METHOD FOR XYLENE
Principle of the Method
Xylene vapor trapped on charcoal from a known volume of air is 
desorbed with carbon disulfide. An aliquot of the desorbed sample is 
injected into a gas chromatograph. The area of the resulting peak is 
determined and compared with areas obtained from injection of standards.
Range and Sensitivity
The lower limit of detection of the analytical procedure was found to 
be less than 12 ¿¿g/sample.
Interferences
When the amount of water in the air is so great that condensation 
actually occurs in the tube, organic vapors will not be trapped. Prelimi­
nary experiments indicate that high humidity severely decreases the amount 
of organic vapor which can be collected before breakthrough of the primary 
adsorbing section occurs. The capacity of the charcoal tube for xylene may 
also be reduced by the presence of another organic vapor in high 
concentration.
Any compound which has about the same retention time as one of the 
xylene isomers at the gas chromatographic conditions described in this 
method will interfere with the analysis. This type of interference can be
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overcome by changing the operating conditions of the instrument, usually 
the column and/or the column temperature.
Precision and Accuracy
In a collaborative test, [101] the total relative error in the range
of 60-200 ppm (260-870 mg/cu m) was 9.5%. At approximately 5 ppm (20 mg/cu
m) this error was 13%.
Advantages and Disadvantages of the Method
The sampling device is small, portable, and involves no liquids. 
Interferences are minimal and most can be eliminated by altering the 
chromatographic conditions. The analysis is accomplished using a rapid 
instrumental method, which can also be used for the simultaneous analysis 
of 2 or more solvents present in the same sample by changing gas 
chromatographic conditions from isothermal to a temperature-programmed mode 
of operation.
One disadvantage of the method is that the amount of sample which can
be taken is limited by the number of milligrams that the tube will hold
before overloading. When the sample value obtained for the backup section 
of the charcoal trap exceeds 20% of that found on the front section, the 
possibility of sample loss exists.
The precision of the method is limited by the reproducibility of the 
pressure drop across the tubes. This drop will affect the flow rate and 
cause the volume to be imprecise, because the pump is usually calibrated 
for one tube only.
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Apparatus
(a) Gas chromatograph equipped with a flame ionization detector.
(b) Column (20 ft x 1/8 in) with 10% FFAP stationary phase on
80/100 mesh acid washed DMCS Chromosorb W solid support. Other columns 
which achieve the desired separation may be used.
(c) A mechanical or electronic integrator or a recorder and some 
method for determining peak area.
(d) Small glass-stoppered test tubes or equivalent.
(e) Syringes: 10-jul, and convenient sizes for preparation of
standards.
Reagents
(a) Carbon disulfide, chromatographic quality.
(b) Xylene, preferably having an isomer distribution close to that
of the sample.
(c) Bureau of Mines Grade A helium.
(d) Prepurified hydrogen.
(e) Filtered compressed air.
Analysis of Samples
All glassware used for the laboratory analysis should be washed in 
detergent followed by tap and distilled water rinses.
(a) Preparation: Each charcoal tube, including the blank from
field samples, is scored with a file and broken open in front of the first 
section of charcoal. The glass wool is removed and discarded. The
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charcoal in the first (larger) section is transferred to a small stoppered 
test tube. The foam separating section is removed and discarded, and the 
second section of charcoal is transferred to another test tube. The 2 
charcoal sections are then analyzed separately.
(b) Desorption: Prior to analysis, 0.5 ml of carbon disulfide is
pipetted into each test tube to desorb the xylene from the charcoal. 
Desorption is complete in 30 minutes if the sample is stirred occasionally.
EXTREME CAUTION MUST BE EXERCISED AT ALL TIMES WHEN USING CARBON
DISULFIDE BECAUSE OF ITS HIGH TOXICITY AND FIRE AND EXPLOSION
HAZARDS. IT CAN BE IGNITED BY HOT STEAM PIPES. ALL WORK WITH
CARBON DISULFIDE MUST BE PERFORMED UNDER AN EXHAUST HOOD.
(c) Typical gas chromatographic operating conditions:
(1) 40 cc/min (70 psig) helium carrier gas flow.
(2) 65 cc/min (24 psig) hydrogen gas flow to detector.
(3) 500 cc/min (50 psig) airflow to detector.
(4) 200 C injector temperature.
(5) 200 C manifold temperature (detector).
(6) 110 C isothermal oven or column temperature.
(d) Injection: The first step in the analysis is the injection of
the sample into the gas chromatograph. The solvent flush injection 
technique is employed. This eliminates difficulties arising from blowback 
or distillation within the syringe needle, thus increasing the accuracy and 
reproducibility of the injected sample volume. The 10.0-jul syringe is 
first flushed with solvent several times to wet the barrel and plunger, 
then 3.0 jul of solvent are drawn into the syringe. Next, the needle is 
removed from the solvent and the plunger is pulled back about 0.2 Ail to
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separate the solvent flush from the sample with an air pocket to be used as 
a marker. The needle is then immersed in the sample and a 5.0-/zl aliquot 
is withdrawn, taking into consideration the volume of the needle, since the
sample in the needle will be completely injected. After the needle is
removed from the sample and prior to injection in the gas chromatograph,
the plunger is pulled back a short distance to minimize sample evaporation 
from the needle tip. Duplicate injections should be made of each sample 
and of the standard. No more than a 3% difference should result in the
peak areas that are recorded.
(e) Measurement of area: The areas of the sample peaks are
measured by an electronic integrator or some other suitable form of area 
measurement and preliminary sample results are read from a standard curve 
prepared as outlined below. The integration of the signals from all three 
xylene isomers is recommended.
Determination of Desorption Efficiency
The desorption efficiency of a particular compound can vary from one 
laboratory to another and also ^rom one batch of charcoal to another. Thus 
it is necessary to determine at least once the percentage of xylene that is 
removed in the desorption process. This procedure should be repeated for 
each new batch of charcoal used. The Physical and Chemical Analysis Branch 
of NIOSH has found desorption efficiencies for xylene varying from 92-99% 
between batches.
Activated charcoal equivalent to the amount in the first section of 
the sampling tube (100 mg) is measured into a 5-cm, 4-mm ID glass tube, 
flame-sealed at one end. This charcoal must be from the same batch as that
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used in obtaining the samples and can be obtained from unused charcoal 
tubes. The open end is capped with Parafilm or equivalent. A known amount 
of xylene is injected directly into the activated charcoal with a micro­
liter syringe, and the tube is capped with more Parafilm or equivalent. A 
known amount injected is usually equivalent to that present in a 10-liter 
sample at a concentration equal to the federal limit of 100 ppm, or about 
4.3 mg.
At least 5 tubes are prepared in this manner and allowed to stand 
overnight or longer to assure complete adsorption of the xylene onto the 
charcoal. These 5 tubes are referred to as the samples. A parallel blank 
tube should be treated in the same manner except that no xylene is added to 
it. The sample and blank tubes are desorbed and analyzed in exactly the 
same manner as the sampling tube described for unknown air samples.
Two or 3 standards are prepared by injecting the same volume of 
xylene into 0.5 ml of carbon disulfide with the same syringe used in the 
preparation of the sample. These are analyzed with the samples.
The desorption efficiency equals the difference between the average 
peak area of the samples and the peak area of the blank divided by the 
average peak area of the standards, or:
desorption efficiency = area sample - area blank
area standard
Calibration and Standards
It is convenient to express the concentration of standards in terms 
of mg/0.5 ml carbon disulfide, because samples are desorbed in this amount 
of carbon disulfide. The density of the xylene is used to convert
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milligrams into microliters for easy measurement with a microliter syringe. 
A series of standards, varying in concentration over the range of interest, 
is prepared and analyzed under the same gas chromatographic conditions and 
during the same time period as the unknown samples. Curves are established 
by plotting concentration in mg/0.5 ml versus peak area.
Calculations
The weight in mg, corresponding to the total peak area, is read from 
the standard curve. No volume corrections are needed, because the standard 
curve is based on mg/0.5 ml carbon disulfide and the volume of sample 
injected is identical to the volume of the standards injected.
Corrections for the blank from the field sampling are made for each 
sample by subtracting the amounts of xylene found on the front and back 
sections of the blank from the amounts found in the respective sections of 
the sample:
Corrected amount = amount on sample - amount on blank
The corrected amounts present in the front and backup sections of the 
same sample tube are added to determine the total amount of xylene in the 
sample. This total amount is divided by the desorption efficiency to 
obtain the adjusted total amount of xylene in the sample.
The volume of air sampled is converted to standard conditions of 25 C 
and 760 mm Hg:
Adjusted total amount =  total amount
desorption efficiency
88
The concentration of xylene in the air sampled, expressed in mg/cu m 
(which is numerically equal to ¿ig/liter of air) is given by the quotient of 
the adjusted amount in /ig divided by the volume of air sampled in liters:
concentration (jug/liter) = adjusted amount pig)
volume (liters)
Another method of expressing concentration is ppm:
concentration (ppm) * concentration (¿ig) x 24.45 x 760 x (T + 273)
106 P 298
where:
24.45 = molar volume (liter/mole) at 25 C and 760 Torr 
106 = molecular weight of xylene (g/mole)
760 = standard pressure
P = pressure (Torr) of air sampled
T = temperature (degrees C) of air sampled
298 = standard temperature (degrees K)
or
concentration (ppm) = concentration (j^tg) x 0.588 (T + 273)
P
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IX. APPENDIX III 
MATERIAL SAFETY DATA SHEET
The following items of information which are applicable to a specific 
product or material containing xylene shall be provided in the appropriate 
section of the Material Safety Data Sheet or other approved form. If a 
specific item of information is inapplicable (eg, flash point), the 
initials "na" (not applicable) should be inserted.
(a) Section I. Source and Nomenclature.
(1) The name, address, and telephone number of the 
manufacturer or supplier of the product.
(2) The trade name and synonyms for a mixture of chemicals, 
a basic structural material, or for a process material; and the trade name 
and synonyms, chemical name and synonyms, chemical family, and formula for 
a single chemical.
(b) Section II. Hazardous Ingredients.
(1) Chemical or widely recognized common name of all 
hazardous ingredients.
(2) The approximate percentage by weight or volume 
(indicate basis) which each hazardous ingredient of the mixture bears to 
the whole mixture. This may be indicated as a range or maximum amount, eg, 
10-20% by volume; 10% maximum by weight.
(3) Basis for toxicity for each hazardous material such as 
an established standard, in appropriate units.
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(c) Section III. Physical Data.
Physical properties of the total product including boiling point and 
melting point in degrees Fahrenheit; vapor pressure, in millimeters of 
mercury, vapor density of gas or vapor (air = 1), solubility in water, in 
parts per hundred parts of water by weight; specific gravity (water * 1);
percent volatile (indicate if by weight or volume) at 70 Fahrenheit; 
evaporation rate for liquids (indicate whether butyl acetate or ether = 1); 
and appearance and odor.
(d) Section IV. Fire and Explosion Hazard Data.
Fire and explosion hazard data about a single chemical or a mixture 
of chemicals, including flash point, in degrees Fahrenheit; flammable 
limits, in percent by volume in air; suitable extinguishing media or 
agents; special firefighting procedures; and unusual fire and explosion 
hazard information.
(e) Section V. Health Hazard Data.
Toxic level for total compound or mixture, effects of exposure, and
emergency and first aid procedures.
(f) Section VI. Reactivity Data.
Chemical stability, incompatibility, hazardous decomposition 
products, and hazardous polymerization.
(g) Section VII. Spill or Leak Procedures.
Detailed procedures to be followed with emphasis on precautions to be 
taken in cleaning up and safe disposal of materials leaked or spilled. 
This includes proper labeling and disposal of containers containing 
residues, contaminated absorbents, etc.
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(h) Section VIII. Special Protection Information.
Requirements for personal protective equipment, such as respirators,
eye protection and protective clothing, and ventilation such as local 
exhaust (at site of product use or application), general, or other special 
types.
(i) Section IX. Special Precautions.
Any other general precautionary information.
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U.S. DEPARTMENT OF LABOR 
Occupational Safety and Health Administration
MATERIAL S A F E T Y  DATA SHEET
F o rm  A p p ro ve d  
O M B  N o. 44 -R 1 3 87
Required under U S D L  Safety and Health Regulations for Ship Repairing, 
Shipbuilding, and Shipbreaking (29  CFR 1915, 1916, 1917)
SECTION 1
M A N U F A C T U R E R ’S N A M E E M E R G E N C Y  T E L E P H O N E  N O .
a d d r e s s  (Number, Street, City, State, and ZIP Code)
c h e m i c a l  n a m e  a n d  s y n o n y m s T R A D E  N A M E  A N D  S Y N O N Y M S
C H E M IC A L  F A M IL Y F O R M U L A
SECTION II - HAZARDOUS INGREDIENTS
PAINTS, PRESERVATIVES, & SOLVENTS % TLV(Units) ALLOYS AND METALLIC COATINGS %
TLV
(Units)
P IG M E N T S B A S E  M E T A L
C A T A L Y S T A L L O Y S
V E H IC L E M E T A L L IC  C O A T IN G S
S O L V E N T S F IL L E R  M E T A LPLUS C O A T IN G  OR C O R E  F L U X
A D D IT IV E S O T H E R S
O T H E R S
HAZARDOUS MIXTURES OF OTHER LIQUIDS, SOLIDS, OR GASES %
TLV
(Unit«)
SECTION III - PHYSICAL DATA
B O IL IN G  P O IN T  (°F .) S P E C IF IC  G R A V IT Y  (H 2 0 = 1 )
V A P O R  P R ESSUR E (m m  Hg.) P E R C E N T, V O L A T IL E  BY  V O L U M E  (%)
V A P O R  D E N S IT Y  (A IR = 1 ) E V A P O R A T IO N  R A T E
( = D
S O L U B IL IT Y  IN  W A T E R
A P P E A R A N C E  A N D  O D O R
SECTION IV - FIRE AND EXPLOSION HAZARD DATA
F L A S H  P O IN T  (M e th od  used) F L A M M A B L E  L IM IT S Lei
E X T IN G U IS H IN G  M E D IA
S P E C IA L  F IR E  F IG H T IN G  P R O C E D U R E S
U N U S U A L  F IR E  A N D  E X P L O S IO N  H A Z A R D S
PAGE (1) (Continued on reverse side)
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SECTION V - HEALTH HAZARD DATA
T H R E S H O L D  L IM IT  V A L U E
E FF E C T S  O F  O V E R E X P O S U R E
E M E R G E N C Y  A N D  F IR S T  A ID  P R O C E D U R E S
SECTION VI - REACTIVITY DATA
S T A B IL IT Y U N S T A B L E C O N D IT IO N S  T O  A V O ID
S T A B L E
IN C O M P A T  I b i l i t y  (Materials to avoid)
H A Z A R D O U S  D E C O M P O S IT IO N  P R O D U C TS
H A Z A R D O U S
P O L Y M E R IZ A T IO N
M A Y  O C C UR
C O N D IT IO N S  T O  A V O ID
W IL L  N O T  O C C UR
SECTION V II - SPILL OR LEAK PROCEDURES
STEPS T O  BE T A K E N  IN C ASE M A T E R IA L  IS R E L E A S E D  O R  S P IL L E D
W A S T E  D IS P O S A L  M E T H O D
SECTION V III - SPECIAL PROTECTION INFORMATION
r e s p i r a t o r y  p r o t e c t i o n  (Specify type)
V E N T IL A T IO N L O C A L  E X H A U S T S P E C IA L
m e c h a n i c a l  (General) O T H E R
P R O T E C T IV E  G L O V E S E Y E  P R O T E C T IO N
O T H E R  P R O T E C T IV E  E Q U IP M E N T
SECTION IX - SPECIAL PRECAUTIONS
P R E C A U T IO N S  T O  BE T A K E N  IN  H A N D L IN G  A N D  S T O R IN G
O T H E R  P R E C A U T IO N S
PAGE (2)
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X. TABLES AND FIGURE 
TABLE X-I
PHYSICAL PROPERTIES OF XYLENE ISOMERS
o-xylene m-xylene p-xylene
Specific gravity 
(25/4 C)
Vapor density 
(air = 1)
Freezing point
Boiling point
Density of saturated 
vapor-air mixture 
at 760 mm and 25 C 
(air = 1)
Flammable limits 
(% in air)
Vapor pressure 
(mm Hg) at 25 C
Flash point (closed cup)
Conversion factors 
(760 mm and 25 C)
0.8758
3.7
-25.2 C 
144.4 C
1. 02  
1.1-6.4 
5.2 
17.2 C
0.8598
3.7
-47.9 C 
139.1 C
1.03 
1 .1- 6 . 4
8.3 
25.0 C
0.8567
3.7
+13.3 C 
138.4 C
1.03 
1 .1- 6 . 6
8.6 
25.0 C
1 ppm = 4.35 mg/cu m 
1 mg/cu m = 0.230 ppm
from ANSI Z37.10-1971 [1]
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TABLE X-2
Measured 
Number:
HUMAN SENSORY THRESHOLDS FOR MIXED XYLENES
Concentration (ppm) 106 233 454
Volunteers 6 7 6
Detecting Odor 6 7 6
Olfactory Fatigue 3 3 3
Throat Irritation 1 0 1
Eye Irritation 0 1 4
With Tears 0 1 1
Reporting Dizziness 0 1 1
Tasting "Something" 0 1 0
With Effects 10 min after Exposure 0 0 0
from Carpenter et al [19]
TABLE X-3
URINARY EXCRETION OF METHYLHIPPURIC ACID AFTER XYLENE EXPOSURE
Sampling (hours) 0-3 4-8 0-8
V£>
m-xylene p-xylene m-xylene p-xylene m-xyl'ene p-xylei
ppm 100 200 100 100 200 100 100 200 100
Uncorrected Mean 1.75 3.59 2.11 3.14 5.79 1.42 1.86 4.56 1.45
(mg/ml) SD 0.85 0.65 1.27 1.50 0.91 0.10 0.48 0.49 0.10
Corrected Mean 1.78 3.19 2.26 2.63 5.58 3.09 2.39 5.32 2.50
(mg/ml) SD 0.61 0.46 0.96 0.75 1.33 0.82 0.33 0.24 0.69
Rate Mean 1.69 3.89 1.56 2.16 4.49 2.11 1.78 4.10 1.75
(mg/min) SD 0.29 0.89 0.23 0.19 1.15 0.77 0.34 0.84 0.21
from Ogata et al [112]
SCREENING LEVELS OF METHYLHIPPURIC ACID IN URINE 
OF WORKERS EXPOSED TO m-XYLENE OR p-XYLENE
TABLE X-4
Exposure period (hours)
7 0-3 4-8
(mg/min) (mg/ml)
m-xylene 1.10 0.56 1.13
p-xylene 1.33 0.34 1.45
from Ogata et al [112]
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TABLE X-5
XYLENE EXPOSURE LIMITS
Country mg/cu m £21
Bulgaria 100 23*
Czechoslovakia 200 46
(Single Exposure) 1,000 230
Finland 870 200
Germany (Federal Republic) 870 200
Hungary 50 12*
Japan 670 150
Poland 100 23*
Rumania 200 46*
United States 870 200
Florida 870* 200
Hawaii 870* 200
Massachusetts 435* 100
Mississippi 870* 200
Pennsylvania 870* 200
(30-minutes) 1,300* 300
South Carolina 870* 200
USSR 50 12*
Yugoslavia 400 100
^Equivalent values calculated by NIOSH 
from reference 36
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FIGURE X-l
CALIBRATION SETUP FOR PERSONAL SAMPLING PUMP WITH CHARCOAL TUBE
D E P A R TM E N T O F  
H E A LTH , E D U C A TIO N , A N D  W E L F A R E
P U B L IC  H E A L T H  S E R V IC E  
CENTER FOR D ISEASE C O N TR O L 
N A T IO N A L  IN S T IT U T E  FOR O C C U P A T IO N A L  SAFETY A N D  H E A LTH  
RM. 5 3 2 ,  U . S. POST O F F IC E , C IN C IN N A T I. O H IO  4 5 2 0 2
P O S T A G E  A N D  P E E S  P A ID  
U .S .  D E P A R T M E N T  O F  H .E .W .  
H E W  3 9 9
O F F IC IA L  B U S IN E S S  
P E N A LTY  FOR P R IV A TE  USE. $ 3 0 0
H E W  Publ icat ion  No. (NIOSH) 7 5 - 1 6 8
